Page 11234..10..»

Archive for the ‘Life Extension’ Category

Pfenex to Participate in the William Blair Growth Stock Conference – GlobeNewswire

SAN DIEGO, June 05, 2020 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) announced today that Eef Schimmelpennink, President and Chief Executive Officer, will participate in a fire side chat at the William Blair Growth Stock Conference on June 9, 2020. The discussion will be virtual and accessible at http://www.wsw.com/webcast/blair56/pfnx.

Interested parties can access the live audio webcast and archive from the Investors Section of Pfenex's website at http://www.pfenex.com.

About Pfenex Inc.Pfenex is a development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology to develop and improve protein therapies for unmet patient needs. Using the patented Pfenex Expression Technology platform, Pfenex has created an advanced pipeline of potential therapeutic equivalents, and vaccines. Pfenexs lead product candidate is PF708, a therapeutic equivalent candidate to Forteo (teriparatide injection). PF708 has been approved in the U.S. for the treatment of osteoporosis in certain patients at high risk for fracture, and marketing authorization applications are pending in other jurisdictions. In addition, Pfenex is developing hematology/oncology products in collaboration with Jazz Pharmaceuticals, including PF743, a recombinant crisantaspase, and PF745, a recombinant crisantaspase with half-life extension technology. Pfenex also uses its Pfenex Expression Technology platform to produce CRM197, a diphtheria toxoid carrier protein used in prophylactic and therapeutic vaccines.

Pfenex investors and others should note that Pfenex announces material information to the public about Pfenex through a variety of means, including its website (http://www.pfenex.com/), its investor relations website (http://pfenex.investorroom.com/), press releases, SEC filings, public conference calls, corporate Twitter account (https://twitter.com/pfenex), Facebook page (https://www.facebook.com/Pfenex-Inc-105908276167776/timeline/), and LinkedIn page (https://www.linkedin.com/company/pfenex-inc) in order to achieve broad, non-exclusionary distribution of information to the public and to comply with its disclosure obligations under Regulation FD. Pfenex encourages its investors and others to monitor and review the information Pfenex makes public in these locations as such information could be deemed to be material information. Please note that this list may be updated from time to time.

Company Contact:investorrelations@pfenex.com

See the original post here:
Pfenex to Participate in the William Blair Growth Stock Conference - GlobeNewswire

Enel Awarded 106.3 MW in Italy in GSE’s Second Auction – Saurenergy

Enel Green Power has announced that it has been awarded 68 MW of new renewable capacity for two wind projects and 38.3 MW of nominal capacity deriving from the repowering of already-operational hydro plants in the second renewable auction launched by the state-owned energy service company GSE (Gestore Servizi Energetici) in Italy.

Specifically, the company participated in the 500 MW tender for new wind and solar projects and the 98.5 MW tender for renovations of renewable plants with a capacity exceeding 1 MW.

Regarding the new capacity, the two wind farms are located in Campania and Basilicata. The upgrading and useful life extension concern the three hydro plants already operating in the municipalities of Castiglione dei Pepoli (Bologna), Civitella in Val di Chiana (Arezzo) and Montecreto (Modena).

With this second award we confirm the commitment to invest in new renewable capacity in Italy, contributing to the challenging decarbonisation objectives of the Enel Group and the country,saidAntonio Cammisecra, CEO of Enel Green Power and Head of the Global Power Generation business line. Thanks to our development strategy, in 2019 the Groups installed capacity from renewables exceeded that from thermal sources globally, marking a further step forward towards the progressive replacement of fossil fuels with zero-emission ones.

The firm has stated that the construction of new capacity and the upgrading of existing plants in Italy are part of the wider commitment of the Enel Group to the growth of renewables and to decarbonisation which in our country foresees, in the 2020-2022 period, the development of new renewable capacity for around 700 MW and for which EGP has developed a pipeline of approximately 1.3 GW of opportunities that can start operating in the same period.

In the second auction conducted by GSE, wind won 406 MW of the 425 MW awarded in an undersubscribed auction 500 MW was on offer.

The primary reason for the undersubscription is Italys cumbersome and lengthy permitting process, stated WindEurope. Besides the challenges with permitting, the auction was also undersubscribed because repowering projects were not allowed to bid. This is significant. Italy has huge repowering potential: almost half of Italys installed wind fleet (10 GW) will reach the end of its operational life by 2030. The fact that repowering projects could not bid in the auction makes no sense.

Onshore wind accounted for the entire 406 MW of the 425 MW awarded in the most recent auction. The price range was from EUR 56/MWh to EUR 68.4/MWh. The weighted average was EUR 64.6/MWh.

Go here to read the rest:
Enel Awarded 106.3 MW in Italy in GSE's Second Auction - Saurenergy

Aeris Resources to acquire producing gold mine from Evolution in transformational move – Proactive Investors Australia

The Cracow Gold Mine is on track to produce 82,500 87,500 ounces of gold in the 2020 financial year and generate net mine cash flow of $84 to $89 million.

() has entered into a binding agreement with () to acquire the Cracow Gold Mine in Queensland.

Cracow is an established, high grade, low-cost underground gold mining operation and processing facility operating continuously since 2004, producing more than 1.4 million ounces over its life, with a consistent track record of profitability and reserve replacement.

The mine is on track to produce 82,500 87,500 ounces of gold in the 2020 financial year and generate net mine cash flow of $84 to $89 million.

Aeris has agreed to pay Evolution $60 million in cash upon closing of the transaction, a deferred payment of $15 million on June 30, 2022 plus a 10% net value royalty from July 1, 2022 to June 30, 2027, capped at $50 million.

Completion of the transaction is expected to occur on June 30, 2020.

Aeris executive chairman Andre Labuschagne said: This is a truly transformational transaction for Aeris and will be immediately accretive in value.

The acquisition provides us with asset and commodity diversity, strong cashflow generation and high value synergies.

Cracow will be a perfect fit for the unique skill set of our management team, who have a track record of extracting value and life extensions, as demonstrated at the Tritton mine, and previously with Norton Gold Fields at the Paddington gold mine. Our immediate focus will be on transitioning Cracow into the Aeris culture and aggressively investing in the mine life extension opportunities we have identified.

Labuschagne added: Aeris inherits a well-run, proven operation which has been a consistent performer for Evolution.

Importantly for us, there is a strong operating team in place that has a culture of continuous improvement.

We are confident that Cracow management and the workforce will fit well with Aeris own culture and the renewed focus to reinvesting in mine life extensions which Aeris will bring.

Aeris intends to fund the transaction through a fully underwritten $40 million equity raising and a $30 million acquisition bridge debt facility.

A new $15 million guarantee facility has also been secured to provide for the replacement of financial assurances relating to the mine and will be provided by SPOV (Special Portfolio Opportunity V), a subsidiary of a fund managed by PAG.

The equity raising will be conducted via a fully underwritten institutional placement and an underwritten 2.02 for 1 pro-rata accelerated renounceable entitlement offer.

Aeris has already secured commitments from its three largest shareholders, representing about 60% of the register to commit to participating in the equity raising, subject to a maximum holding of 19.99% at completion.

The Cracow Gold Mine is about 500 kilometres north-west of Brisbane in a highly endowed goldfield with gold mineralisation hosted in steeply dipping structurally controlled low sulphidation epithermal veins.

The underground mine is accessed through a single surface decline with ore primarily mined via open stoping through a modified Avoca mining sequence.

Cracow has a strong track record of reserve and resource replacement and Aeris plans to aggressively invest in brownfield and greenfield exploration with the aim of growing the resource base to extend mine life.

Multiple near term opportunities for resource conversion have been identified with about $13 million budgeted over the next two years for exploration, with key priorities including both underground near-mine extensions (e.g. Killarney) as well as nearby open-pit deposits (e.g. the Golden Plateau and Roses Pride).

Extracting value through integration efficiencies will also be a key driver of Aeris immediate plan with about $4 million of targeted annual cost synergies as well as the potential for utilising Aeris existing carried forward tax losses ($256 million at June 30, 2019).

Over the two year period to June 30, 2022, Aeris expects Cracow to generate more than $100 million of net mine cash flows at the current gold price, with pro forma Aeris group EBITDA of $272 million to $282 million and pro forma group net mine cash flows of $137 million to $155 million.

This significant cashflow will provide for both investment in life of mine extension projects at Cracow and Tritton as well as to also continue deleveraging Aeris balance sheet.

To protect the very significant near term positive cashflows from Cracow, Aeris intends to enter a prudent gold hedging program, with an initial focus on the first 12 months.

See more here:
Aeris Resources to acquire producing gold mine from Evolution in transformational move - Proactive Investors Australia

Coral Springs Approves Spending of At Least $679800 on Projects and Expenses – TAPinto.net

CORAL SPRINGS, FL Swimming coach. Fire equipment. Medical evaluations.

These were among the projects and expenses approved Wednesday by Coral Springs City Commission at a cost of at least $679,800.

Heres what commissioners approved during their June 3 public meeting:

Our newsletter delivers the local news that you can trust.

- Swim coach services from July 1, 2020 to June 30, 2022. Swim Phish, Inc. of Coral Springs will get annual stipend of $25,000.

- Fire equipment parts, supplies, and service from July 1, 2020 to June 30, 2021. Ten-8 Fire Equipment, Inc. of Bradenton, Fla, will get estimated annual payment of $75,000.

- Tandem axle truck. SBL Freightliner LLC/Lou Bachrodt Freightliner of Pompano Beach will be paid $127,170.

- Maintenance and inspection of building automation systems citywide from June 4, 2020 to June 3, 2021. Design Controls, Inc/DCI Systems Group, Inc. of Oakland Park will get annual payment of up to $100,000.

- Medical evaluations/physicals. Life Extension Clinics, Inc. of Tampa will get annual payment of $140,000.

- Security guard services from June 16 to March 8, 2025. Universal Protection Service, LLC/Allied Universal Security Services, LLC of Santa Ana, Ca. will get annual payment of $212,800.

Follow us on Facebook and Twitter and sign up for FREE TAPinto Coral Springs E-News alerts to be the first to read about all things Coral Springs.

Download the FREE TAPinto App.Click here for Android-Click here for iOSfor breaking news, traffic/weather alerts, and special offers.

Know a story we should share with our readers? Email editor Leon Fooksman (lfooksman@tapinto.net) and tell him about it.

Read more from the original source:
Coral Springs Approves Spending of At Least $679800 on Projects and Expenses - TAPinto.net

Eye Health Supplements Market : Prospective Growth Trends & Incremental Opportunity Assessment till… – Azizsalon News

This detailed market study covers eye health supplements market growth potentials which can assist the stake holders to understand key trends and prospects in eye health supplements market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the markets growth potential, which can help investors identify scope and opportunities. The analysis also provides details of each segment in the global eye health supplements market

Get Sample Copy of This Report @https://www.quincemarketinsights.com/request-sample-67629?utm_source=AZ&utm_medium=SG

According to the report, the eye health supplements market report points out national and global business prospects and competitive conditions for eye health supplements. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for eye health supplements. The eye health supplements market has been segmented by ingredient type (lutein and zeaxanthin, antioxidants, omega-3 fatty acids, coenzyme q10, flavonoids, astaxanthin, alpha-lipoic acid, other ingredients), by indication type (age-related macular degeneration (amd), cataract, dry eye syndrome, other indications), by form (tablet, capsule, others). Historical background for the demand of eye health supplements has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand eye health supplements have also been established with potential gravity.

Regional segmentation and analysis to understand growth patterns:

The market has been segmented in major regions to understand the global development and demand patterns of this market.

North America, Europe, and Asia Pacific by region are estimated to dominate the eye health supplements market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favourable for the growth of the healthcare infrastructure in these regions. North America and Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for eye health supplements market during the forecast period.

Get ToC for the overview of the premium report @https://www.quincemarketinsights.com/request-toc-67629?utm_source=AZ&utm_medium=SG

The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for eye health supplements market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for eye health supplements market in the region. Other regions including Middle East, Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for eye health supplements market during the forecast period.

This report provides:

1) An overview of the global market for eye health supplements market and related technologies.2) Analysis of global market trends, yearly estimates and annual growth rate projections for compounds (CAGRs).

3) Identification of new market opportunities and targeted consumer marketing strategies for global eye health supplements market .4) Analysis of R&D and demand for new technologies and new applications5) Extensive company profiles of key players in industry.

Make an Inquiry for purchasing this Report @https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-67629?utm_source=AZ&utm_medium=SG

The researchers have studied the market in depth and have developed important segments such as product type, application and region. Each and every segment and its sub-segments are analyzed based on their market share, growth prospects and CAGR. Each market segment offers in-depth, both qualitative and quantitative information on market outlook.

With an emphasis on strategies there have been several primary developments done by major companies such as Vitabiotics Ltd., Valeant Pharmaceuticals International Inc., Life Extension, Pfizer Inc., OmniActive Health Technologies, Algatechnologies, Alliance Pharma, The Natures Bounty Co., Novartis AG, and Amway Corp.

Market Segmentation:

By Ingredient Type:o Lutein and Zeaxanthino Antioxidantso Omega-3 Fatty Acidso Coenzyme Q10o Flavonoidso Astaxanthino Alpha-Lipoic Acido Other Ingredients

By Indication Type:o Age-related Macular Degeneration (AMD)o Cataracto Dry Eye Syndromeo Other Indications

By Form:o Tableto Capsuleo Others

By Region:

North America Eye Health Supplements Marketo North America, by CountryUSCanadaMexicoo North America, by Ingredient Typeo North America, by Indication Typeo North America, by Form

Europe Eye Health Supplements Marketo Europe, by CountryGermanyRussiaUKFranceItalySpainThe NetherlandsRest of Europeo Europe, by Ingredient Typeo Europe, by Indication Typeo Europe, by Form

Asia Pacific Eye Health Supplements Marketo Asia Pacific, by CountryChinaIndiaJapanSouth KoreaAustraliaIndonesiaRest of Asia Pacifico Asia Pacific, by Ingredient Typeo Asia Pacific, by Indication Typeo Asia Pacific, by Form

Middle East & Africa Eye Health Supplements Marketo Middle East & Africa, by CountryUAESaudi ArabiaQatarSouth AfricaRest of Middle East & Africao Middle East & Africa, by Ingredient Typeo Middle East & Africa, by Indication Typeo Middle East & Africa, by Form

South America Eye Health Supplements Marketo South America, by CountryBrazilArgentinaColombiaRest of South Americao South America, by Ingredient Typeo South America, by Indication Typeo South America, by Form

Reasons to Buy This Report:

o Provides niche insights for decision about every possible segment helping in strategic decision making process.o Market size estimation of the eye health supplements market on a regional and global basis.

o A unique research design for market size estimation and forecast.o Identification of major companies operating in the market with related developmentso Exhaustive scope to cover all the possible segments helping every stakeholder in the eye health supplements

Customization:

This study is customized to meet your specific requirements:

o By Segmento By Sub-segmento By Region/Countryo Product Specific Competitive Analysis

Contact:Quince Market InsightsAjay D. (Knowledge Partner)Office No- A109Pune, Maharashtra 411028Phone: US +1 208 405 2835 UK +44 121 364 6144 APAC +91 706 672 4848Email: sales@quincemarketinsights.comWeb:www.quincemarketinsights.com

ABOUT US:QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

See original here:
Eye Health Supplements Market : Prospective Growth Trends & Incremental Opportunity Assessment till... - Azizsalon News

Reishi Mushroom Supplements Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026 – Weekly…

The market research report is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Reishi Mushroom Supplements market. It informs readers about key trends and opportunities in the global Reishi Mushroom Supplements market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global Reishi Mushroom Supplements market.

Key companies operating in the global Reishi Mushroom Supplements market include , Natures Way Reishi, Solaray Reishi Mushroom, Life Extension Reishi Extract, Host Defense Reishi, Terrasoul Superfoods, Swanson Reishi Mushroom, Aloha Medicinals, Mushroom Science, Planetary Herbals Reishi Mushroom Supplements

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1733074/global-reishi-mushroom-supplements-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Reishi Mushroom Supplements market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Reishi Mushroom Supplements Market Segment By Type:

, Organic Reishi Mushroom Supplements, Inorganic Reishi Mushroom Supplements Reishi Mushroom Supplements

Global Reishi Mushroom Supplements Market Segment By Application:

, Online Sales, Offline Sales

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Reishi Mushroom Supplements market.

Key companies operating in the global Reishi Mushroom Supplements market include , Natures Way Reishi, Solaray Reishi Mushroom, Life Extension Reishi Extract, Host Defense Reishi, Terrasoul Superfoods, Swanson Reishi Mushroom, Aloha Medicinals, Mushroom Science, Planetary Herbals Reishi Mushroom Supplements

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1733074/global-reishi-mushroom-supplements-market

TOC

1 Study Coverage1.1 Reishi Mushroom Supplements Product Introduction1.2 Market Segments1.3 Key Reishi Mushroom Supplements Manufacturers Covered: Ranking by Revenue1.4 Market by Type 1.4.1 Global Reishi Mushroom Supplements Market Size Growth Rate by Type 1.4.2 Organic Reishi Mushroom Supplements 1.4.3 Inorganic Reishi Mushroom Supplements1.5 Market by Application 1.5.1 Global Reishi Mushroom Supplements Market Size Growth Rate by Application 1.5.2 Online Sales 1.5.3 Offline Sales1.6 Coronavirus Disease 2019 (Covid-19): Reishi Mushroom Supplements Industry Impact 1.6.1 How the Covid-19 is Affecting the Reishi Mushroom Supplements Industry 1.6.1.1 Reishi Mushroom Supplements Business Impact Assessment Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Reishi Mushroom Supplements Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Reishi Mushroom Supplements Players to Combat Covid-19 Impact1.7 Study Objectives1.8 Years Considered 2 Executive Summary2.1 Global Reishi Mushroom Supplements Market Size Estimates and Forecasts 2.1.1 Global Reishi Mushroom Supplements Revenue 2015-2026 2.1.2 Global Reishi Mushroom Supplements Sales 2015-20262.2 Reishi Mushroom Supplements Market Size by Region: 2020 Versus 2026 2.2.1 Global Reishi Mushroom Supplements Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Reishi Mushroom Supplements Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Reishi Mushroom Supplements Competitor Landscape by Players3.1 Reishi Mushroom Supplements Sales by Manufacturers 3.1.1 Reishi Mushroom Supplements Sales by Manufacturers (2015-2020) 3.1.2 Reishi Mushroom Supplements Sales Market Share by Manufacturers (2015-2020)3.2 Reishi Mushroom Supplements Revenue by Manufacturers 3.2.1 Reishi Mushroom Supplements Revenue by Manufacturers (2015-2020) 3.2.2 Reishi Mushroom Supplements Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Reishi Mushroom Supplements Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Reishi Mushroom Supplements Revenue in 2019 3.2.5 Global Reishi Mushroom Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Reishi Mushroom Supplements Price by Manufacturers3.4 Reishi Mushroom Supplements Manufacturing Base Distribution, Product Types 3.4.1 Reishi Mushroom Supplements Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Reishi Mushroom Supplements Product Type 3.4.3 Date of International Manufacturers Enter into Reishi Mushroom Supplements Market3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)4.1 Global Reishi Mushroom Supplements Market Size by Type (2015-2020) 4.1.1 Global Reishi Mushroom Supplements Sales by Type (2015-2020) 4.1.2 Global Reishi Mushroom Supplements Revenue by Type (2015-2020) 4.1.3 Reishi Mushroom Supplements Average Selling Price (ASP) by Type (2015-2026)4.2 Global Reishi Mushroom Supplements Market Size Forecast by Type (2021-2026) 4.2.1 Global Reishi Mushroom Supplements Sales Forecast by Type (2021-2026) 4.2.2 Global Reishi Mushroom Supplements Revenue Forecast by Type (2021-2026) 4.2.3 Reishi Mushroom Supplements Average Selling Price (ASP) Forecast by Type (2021-2026)4.3 Global Reishi Mushroom Supplements Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026)5.1 Global Reishi Mushroom Supplements Market Size by Application (2015-2020) 5.1.1 Global Reishi Mushroom Supplements Sales by Application (2015-2020) 5.1.2 Global Reishi Mushroom Supplements Revenue by Application (2015-2020) 5.1.3 Reishi Mushroom Supplements Price by Application (2015-2020)5.2 Reishi Mushroom Supplements Market Size Forecast by Application (2021-2026) 5.2.1 Global Reishi Mushroom Supplements Sales Forecast by Application (2021-2026) 5.2.2 Global Reishi Mushroom Supplements Revenue Forecast by Application (2021-2026) 5.2.3 Global Reishi Mushroom Supplements Price Forecast by Application (2021-2026) 6 North America6.1 North America Reishi Mushroom Supplements by Country 6.1.1 North America Reishi Mushroom Supplements Sales by Country 6.1.2 North America Reishi Mushroom Supplements Revenue by Country 6.1.3 U.S. 6.1.4 Canada6.2 North America Reishi Mushroom Supplements Market Facts & Figures by Type6.3 North America Reishi Mushroom Supplements Market Facts & Figures by Application 7 Europe7.1 Europe Reishi Mushroom Supplements by Country 7.1.1 Europe Reishi Mushroom Supplements Sales by Country 7.1.2 Europe Reishi Mushroom Supplements Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia7.2 Europe Reishi Mushroom Supplements Market Facts & Figures by Type7.3 Europe Reishi Mushroom Supplements Market Facts & Figures by Application 8 Asia Pacific8.1 Asia Pacific Reishi Mushroom Supplements by Region 8.1.1 Asia Pacific Reishi Mushroom Supplements Sales by Region 8.1.2 Asia Pacific Reishi Mushroom Supplements Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam8.2 Asia Pacific Reishi Mushroom Supplements Market Facts & Figures by Type8.3 Asia Pacific Reishi Mushroom Supplements Market Facts & Figures by Application 9 Latin America9.1 Latin America Reishi Mushroom Supplements by Country 9.1.1 Latin America Reishi Mushroom Supplements Sales by Country 9.1.2 Latin America Reishi Mushroom Supplements Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina9.2 Central & South America Reishi Mushroom Supplements Market Facts & Figures by Type9.3 Central & South America Reishi Mushroom Supplements Market Facts & Figures by Application 10 Middle East and Africa10.1 Middle East and Africa Reishi Mushroom Supplements by Country 10.1.1 Middle East and Africa Reishi Mushroom Supplements Sales by Country 10.1.2 Middle East and Africa Reishi Mushroom Supplements Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E10.2 Middle East and Africa Reishi Mushroom Supplements Market Facts & Figures by Type10.3 Middle East and Africa Reishi Mushroom Supplements Market Facts & Figures by Application 11 Company Profiles11.1 Natures Way Reishi 11.1.1 Natures Way Reishi Corporation Information 11.1.2 Natures Way Reishi Description, Business Overview and Total Revenue 11.1.3 Natures Way Reishi Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Natures Way Reishi Reishi Mushroom Supplements Products Offered 11.1.5 Natures Way Reishi Recent Development11.2 Solaray Reishi Mushroom 11.2.1 Solaray Reishi Mushroom Corporation Information 11.2.2 Solaray Reishi Mushroom Description, Business Overview and Total Revenue 11.2.3 Solaray Reishi Mushroom Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Solaray Reishi Mushroom Reishi Mushroom Supplements Products Offered 11.2.5 Solaray Reishi Mushroom Recent Development11.3 Life Extension Reishi Extract 11.3.1 Life Extension Reishi Extract Corporation Information 11.3.2 Life Extension Reishi Extract Description, Business Overview and Total Revenue 11.3.3 Life Extension Reishi Extract Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Life Extension Reishi Extract Reishi Mushroom Supplements Products Offered 11.3.5 Life Extension Reishi Extract Recent Development11.4 Host Defense Reishi 11.4.1 Host Defense Reishi Corporation Information 11.4.2 Host Defense Reishi Description, Business Overview and Total Revenue 11.4.3 Host Defense Reishi Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Host Defense Reishi Reishi Mushroom Supplements Products Offered 11.4.5 Host Defense Reishi Recent Development11.5 Terrasoul Superfoods 11.5.1 Terrasoul Superfoods Corporation Information 11.5.2 Terrasoul Superfoods Description, Business Overview and Total Revenue 11.5.3 Terrasoul Superfoods Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Terrasoul Superfoods Reishi Mushroom Supplements Products Offered 11.5.5 Terrasoul Superfoods Recent Development11.6 Swanson Reishi Mushroom 11.6.1 Swanson Reishi Mushroom Corporation Information 11.6.2 Swanson Reishi Mushroom Description, Business Overview and Total Revenue 11.6.3 Swanson Reishi Mushroom Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Swanson Reishi Mushroom Reishi Mushroom Supplements Products Offered 11.6.5 Swanson Reishi Mushroom Recent Development11.7 Aloha Medicinals 11.7.1 Aloha Medicinals Corporation Information 11.7.2 Aloha Medicinals Description, Business Overview and Total Revenue 11.7.3 Aloha Medicinals Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Aloha Medicinals Reishi Mushroom Supplements Products Offered 11.7.5 Aloha Medicinals Recent Development11.8 Mushroom Science 11.8.1 Mushroom Science Corporation Information 11.8.2 Mushroom Science Description, Business Overview and Total Revenue 11.8.3 Mushroom Science Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Mushroom Science Reishi Mushroom Supplements Products Offered 11.8.5 Mushroom Science Recent Development11.9 Planetary Herbals 11.9.1 Planetary Herbals Corporation Information 11.9.2 Planetary Herbals Description, Business Overview and Total Revenue 11.9.3 Planetary Herbals Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Planetary Herbals Reishi Mushroom Supplements Products Offered 11.9.5 Planetary Herbals Recent Development11.1 Natures Way Reishi 11.1.1 Natures Way Reishi Corporation Information 11.1.2 Natures Way Reishi Description, Business Overview and Total Revenue 11.1.3 Natures Way Reishi Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Natures Way Reishi Reishi Mushroom Supplements Products Offered 11.1.5 Natures Way Reishi Recent Development 12 Future Forecast by Regions (Countries) (2021-2026)12.1 Reishi Mushroom Supplements Market Estimates and Projections by Region 12.1.1 Global Reishi Mushroom Supplements Sales Forecast by Regions 2021-2026 12.1.2 Global Reishi Mushroom Supplements Revenue Forecast by Regions 2021-202612.2 North America Reishi Mushroom Supplements Market Size Forecast (2021-2026) 12.2.1 North America: Reishi Mushroom Supplements Sales Forecast (2021-2026) 12.2.2 North America: Reishi Mushroom Supplements Revenue Forecast (2021-2026) 12.2.3 North America: Reishi Mushroom Supplements Market Size Forecast by Country (2021-2026)12.3 Europe Reishi Mushroom Supplements Market Size Forecast (2021-2026) 12.3.1 Europe: Reishi Mushroom Supplements Sales Forecast (2021-2026) 12.3.2 Europe: Reishi Mushroom Supplements Revenue Forecast (2021-2026) 12.3.3 Europe: Reishi Mushroom Supplements Market Size Forecast by Country (2021-2026)12.4 Asia Pacific Reishi Mushroom Supplements Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Reishi Mushroom Supplements Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Reishi Mushroom Supplements Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Reishi Mushroom Supplements Market Size Forecast by Region (2021-2026)12.5 Latin America Reishi Mushroom Supplements Market Size Forecast (2021-2026) 12.5.1 Latin America: Reishi Mushroom Supplements Sales Forecast (2021-2026) 12.5.2 Latin America: Reishi Mushroom Supplements Revenue Forecast (2021-2026) 12.5.3 Latin America: Reishi Mushroom Supplements Market Size Forecast by Country (2021-2026)12.6 Middle East and Africa Reishi Mushroom Supplements Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Reishi Mushroom Supplements Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Reishi Mushroom Supplements Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Reishi Mushroom Supplements Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis13.1 Market Opportunities and Drivers13.2 Market Challenges13.3 Market Risks/Restraints13.4 Porters Five Forces Analysis13.5 Primary Interviews with Key Reishi Mushroom Supplements Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis14.1 Value Chain Analysis14.2 Reishi Mushroom Supplements Customers14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source16.2 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Here is the original post:
Reishi Mushroom Supplements Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026 - Weekly...

Snowbirds were waiting for new ejection seats before deadly crash. Now DND wont say if gear was replaced – Toronto Star

VANCOUVERThe crucial piece of safety equipment that offered the last chance to save the life of Capt. Jenn Casey when she ejected from a Snowbird CT-114 Tutor Jet earlier this month had been targeted for replacement by a much more sophisticated system as far back as 2015, military records show.

Twelve days after the tragedy, the military wont say whether the Canadian Forces fleets ejection seats have yet been replaced, or whether the ejection seats used by Casey and pilot Capt. Richard MacDougall that day were still an outdated technology that the military knew was less effective at saving lives in the flying conditions used by the Snowbirds than more modern systems.

Although the cause of the crash that took place in Kamloops, B.C., moments after the Snowbirds CT-114 Tutor Jet took off is not yet publicly known, one thing is certain: MacDougall and Casey both ejected from the plane, their lives depending on the absolute last resort safety equipment available to them ejection seats.

While MacDougall survived the ejection, Casey did not. And there is no question that modern ejection seat technology the Department of National Defence planned to place in the Snowbirds fleet offers a greater chance of survival for the kinds of scenarios in which the Snowbirds fly, compared to the older ejection seats originally used in the Tutor jets.

Its led aviation safety experts across the country to ask the question: Could the jets technology have given Casey a better chance of survival?

The Department of Defence did not respond to repeated questions about the state of the ejection seats on the jets first built in 1965.

Ejection seats have a certain set of parameters called an envelope in which they will work as expected and give the person ejecting the greatest chance for survival.

State of the art ejection seats work in whats called zero-zero conditions, meaning the plane can be at zero altitude, and zero air speed, and the seat will still rocket the occupant high enough in the air for the parachute to open and the occupant to land safely.

Older ejection seats can also save lives, but they work under more limited conditions. The ejection seats original to the Snowbirds jets were manufactured by Weber Aircraft. According to several experts, the seats work from zero altitude if the plane is travelling at a speed of 60 knots. The direction of the plane also influences the effectiveness of the seat, while this is a less important factor with the zero-zero seats.

In the case of the Snowbirds, they are regularly in high-risk circumstances for ejection: They fly at high speeds, close together, at low altitude and perform aerobatics.

What matters, that most important component of any single-engine, high-speed military aircraft, is that youve got to have an ejector seat that will allow the survival of the occupant in the kind of manoeuvres that the plane performs, said John Pottinger, a longtime aviation safety expert based in Vancouver.

If the Snowbirds are still using the old Weber seats, Pottinger says, We have not reduced the risk to a level most Canadians would consider acceptable.

The military has been aware of the aging nature of the CT-114 ejection system, and has expressed a need to replace it as far back as 2015, when the national Defence Department released a report on a project then called the CT-114 Life Extension Beyond 2020.

The upgrade may include replacing wing components, replacing the ejection seat with a zero/zero capability and improving the wheel breaks to allow operations at remote locations, the 2015 document reads.

An official record of the project under the Department of National Defences investment plan, updated in January makes no mention of ejection seats. In an email, a spokesperson for the department told the Star the project is in the options analysis phase. The spokesperson did not respond to repeated questions about whether the ejection seats have been updated as part of the project.

Media reports from 2016 showed the military did test an updated ejection seat for the CT-114 Tutor off the back of a Dodge Ram. The Department of Defence did not respond to questions about whether that test led to updates to the Tutor jets.

The defence spokesperson wrote in an email that the intention of the CT-114 Life Extension Beyond 2020 is to update the CT-114 jets so theyre usable until 2030. Thats a change from previous plans detailed by the department in 2012 media reports, which said the 1960s jets would be retired by 2020.

The CT-114 Tutor aircraft has proven to be a very resilient platform to maintain and upgrade, a portion of the email reads. On-aircraft maintenance is done by RCAF technicians from 431 Sqn on a regular basis, and an additional Periodic Inspection is completed by IMP Aerospace every 400 flying hours. This includes further maintenance and repairs to ensure the aircraft remains serviceable for first-line operations.

Pottinger, who has worked in aviation safety for more than three decades, including time at Transport Canada, said that when it comes to the age of the Snowbirds fleet, the ejection seat is one of the most important safety features to keep up-to-date.

He said there are two ways to mitigate risk: You can reduce the risk of the activity itself, and you can reduce the consequences of the risky action. For example, when it comes to driving, stop signs are an example of the first way, while seatbelts are an example of the second.

Flight, especially in a single-engine, high-speed jet performing aerobatics close to the ground, is inherently risky, Pottinger said. So the choices National Defence makes about reducing the consequences of risky activity are especially important.

You decide: Can you retrofit one of the more modern ejection seats into Tutor jets, or not?

Start your morning with everything you need to know, and nothing you don't. Sign up for First Up, the Star's new daily email newsletter.

Its possible, due to the size and weight of the Tutor jets, that the answer would be no. In that case, Pottinger said the military would have to consider the cost of replacing the Tutors with newer jets, or stopping the program altogether. But to him, the risk of carrying on the Snowbirds program with inferior ejection technology is unacceptable.

Ejection was also an issue in a Snowbirds crash in October 2019, though it is unclear what went wrong.

An initial investigator report for a crash at the Atlanta Motor Speedway in Georgia, when pilot Capt. Kevin Domon-Grenier successfully ejected and survived, states that Domon-Grenier reported anomalies with the ejection system during the incident.

The crash also brought back memories of the last time a Snowbird member died in a crash.

Every May, Rob Mitchell and his former Snowbirds squadron plan to get together to remember Capt. Shawn McCaughey, who died during an air show practice exactly 13 years ago.

We call it Shawns gift to us, he said. Its that eternal connection.

Already bonded by living, travelling and flying together, Mitchell believes that the Snowbirds crew he headed in 2007 and 2008 were drawn especially close by the terrible tragedy they witnessed. On May 18, 2007, McCaugheys plane crashed during a practice show. His seatbelt failed, and the 31-year-old captain died on the spot.

A report released two years later concluded that a faulty seatbelt system the military had known about and delayed updating for five years contributed to his death.

Almost 13 years later, Mitchell watched the videos of another Snowbirds plane plunging to the ground with disbelief and dread. He saw the two streaks of smoke showing that the pilot and passenger had ejected from the CT-114 Tutor jet.

Ejection, Mitchell said, is nothing like jumping out of an airplane with a parachute. Its high-stakes safety equipment designed to shoot airplane occupants out of the aircraft high enough into the air so that the parachute expands.

The act of ejecting is a very violent thing, it propels you out of a jet at over 20 G, Mitchell said. G-force is short for gravitational force equivalent, a measure of acceleration. By comparison, jets that race in competition have a maximum G-force of 10.

The fact that the pilot of the May 17 crash survived, but Casey did not, left Mitchell with a familiar knot in his stomach, and a puzzle.

Like anything in life, theres a design limitation, air speed, altitude, nose position that is calculated when they make this machinery and there are certain envelopes for that seat and I want to know how close to that envelope they were, Mitchell said.

Being that close to it when one person makes it and one doesnt, it makes you go: What was it that made the difference?

Go here to read the rest:
Snowbirds were waiting for new ejection seats before deadly crash. Now DND wont say if gear was replaced - Toronto Star

Bring the Global Airborne Retrofit & Modernization Market into View – Defense & Security Monitor

The airborne retrofit & modernization (R&M) market is as vast as it is complex. With most aircraft expected to serve their operators for a span of at least 30 years, each produced airframe brings with it not only the initial cost of procurement, but a three-decades-long litany of modifications, retrofits, and Service Life Extension Programs that in some cases may surpass the initial cost of purchase. Forecast Internationals Airborne Retrofit & Modernization Forecast provides clients with an in-depth analysis of ongoing and future retrofit programs for more than 60 key aircraft operated around the globe. With the release of the Airborne Retrofit & Modernization module for Platinum Forecast System 4.4, clients can, for the first time, access the data used to generate our program reports in its entirety.

With the Platinum Forecast System, our data is sortable, customizable, and plentiful. Through years of research, our analysts have identified, analyzed, and reported on significant ongoing and speculative retrofit & modernization programs on aircraft like the Airbus A320, Lockheed Martin C-130H and more, building a library of hard data that is now available for manipulation by our clients.

A subscription to the Airborne Retrofit & Modernization module for Platinum provides not only access to our R&M-related data, but the full roster of individual platform reports and an R&M-tailored news feed, which is updated daily. Through Platinum, our clients can sort by data field, including Date Range, Platform Category, System Data Type, Category of Use and Worldwide Geography, among others, and have access to unprecedented detail, including graphics and tables/spreadsheets with computations of units/values over a 15-year forecast period. With the Airborne Retrofit & Modernization module for Platinum Forecast System 4.4, you can identify competitors in a given segment, highlight key operator nations and prime retrofit candidates within each fleet, and take advantage of opportunities as they arise.

In the weeks and months ahead, accurate and reliable market forecasts will be more critical than ever to achieving success. At this moment of global uncertainty, Forecast International is committed to ensuring you have the market intelligence you need to navigate the challenging road forward.

Read more:
Bring the Global Airborne Retrofit & Modernization Market into View - Defense & Security Monitor

COVID-19 Impact on Melatonine Market Research Report: Probable Key Development To Be Observed Market States And Outlook Across By 2026 – News Distinct

The market research report published by QYResearch is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global COVID-19 Impact on Melatonine market. It informs readers about key trends and opportunities in the global COVID-19 Impact on Melatonine market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global COVID-19 Impact on Melatonine market.

Key companies operating in the global COVID-19 Impact on Melatonine market include , Life Extension, Pharmavite, NOW Foods, Source Naturals, BY-HEALTH, GNC, Centrum, Jamieson Vitamins, Nutraceutical Corporation, Haviland Enterprises Inc., Pharma Resources International LLC, AIE Pharmaceuticals, Gemini Pharmaceuticals, Spectrum Chemical Mfg. Corp., Nutritional Supplement Manufacturers Inc., Van Wankum Ingredients, Action Labs Inc., Softgel Nutraceuticals, Norquay Technology Inc., Arnet Pharmaceutical, Twinlab Corp., Superior Supplement Manufacturing, The Chemical Co. Melatonine

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1711659/covid-19-impact-on-global-melatonine-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global COVID-19 Impact on Melatonine market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global COVID-19 Impact on Melatonine Market Segment By Type:

, Capsule, Pills, Liquid Melatonine

Global COVID-19 Impact on Melatonine Market Segment By Application:

, Hospital, Clinic, Household, Other

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global COVID-19 Impact on Melatonine market.

Key companies operating in the global COVID-19 Impact on Melatonine market include , Life Extension, Pharmavite, NOW Foods, Source Naturals, BY-HEALTH, GNC, Centrum, Jamieson Vitamins, Nutraceutical Corporation, Haviland Enterprises Inc., Pharma Resources International LLC, AIE Pharmaceuticals, Gemini Pharmaceuticals, Spectrum Chemical Mfg. Corp., Nutritional Supplement Manufacturers Inc., Van Wankum Ingredients, Action Labs Inc., Softgel Nutraceuticals, Norquay Technology Inc., Arnet Pharmaceutical, Twinlab Corp., Superior Supplement Manufacturing, The Chemical Co. Melatonine

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1711659/covid-19-impact-on-global-melatonine-market

TOC

1 Study Coverage1.1 Melatonine Product Introduction1.2 Market Segments1.3 Key Melatonine Manufacturers Covered: Ranking by Revenue1.4 Market by Type 1.4.1 Global Melatonine Market Size Growth Rate by Type 1.4.2 Capsule 1.4.3 Pills 1.4.4 Liquid1.5 Market by Application 1.5.1 Global Melatonine Market Size Growth Rate by Application 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Household 1.5.5 Other1.6 Coronavirus Disease 2019 (Covid-19): Melatonine Industry Impact 1.6.1 How the Covid-19 is Affecting the Melatonine Industry 1.6.1.1 Melatonine Business Impact Assessment Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Melatonine Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Melatonine Players to Combat Covid-19 Impact1.7 Study Objectives1.8 Years Considered 2 Executive Summary2.1 Global Melatonine Market Size Estimates and Forecasts 2.1.1 Global Melatonine Revenue 2015-2026 2.1.2 Global Melatonine Sales 2015-20262.2 Melatonine Market Size by Region: 2020 Versus 2026 2.2.1 Global Melatonine Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Melatonine Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Melatonine Competitor Landscape by Players3.1 Melatonine Sales by Manufacturers 3.1.1 Melatonine Sales by Manufacturers (2015-2020) 3.1.2 Melatonine Sales Market Share by Manufacturers (2015-2020)3.2 Melatonine Revenue by Manufacturers 3.2.1 Melatonine Revenue by Manufacturers (2015-2020) 3.2.2 Melatonine Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Melatonine Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Melatonine Revenue in 2019 3.2.5 Global Melatonine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Melatonine Price by Manufacturers3.4 Melatonine Manufacturing Base Distribution, Product Types 3.4.1 Melatonine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Melatonine Product Type 3.4.3 Date of International Manufacturers Enter into Melatonine Market3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)4.1 Global Melatonine Market Size by Type (2015-2020) 4.1.1 Global Melatonine Sales by Type (2015-2020) 4.1.2 Global Melatonine Revenue by Type (2015-2020) 4.1.3 Melatonine Average Selling Price (ASP) by Type (2015-2026)4.2 Global Melatonine Market Size Forecast by Type (2021-2026) 4.2.1 Global Melatonine Sales Forecast by Type (2021-2026) 4.2.2 Global Melatonine Revenue Forecast by Type (2021-2026) 4.2.3 Melatonine Average Selling Price (ASP) Forecast by Type (2021-2026)4.3 Global Melatonine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026)5.1 Global Melatonine Market Size by Application (2015-2020) 5.1.1 Global Melatonine Sales by Application (2015-2020) 5.1.2 Global Melatonine Revenue by Application (2015-2020) 5.1.3 Melatonine Price by Application (2015-2020)5.2 Melatonine Market Size Forecast by Application (2021-2026) 5.2.1 Global Melatonine Sales Forecast by Application (2021-2026) 5.2.2 Global Melatonine Revenue Forecast by Application (2021-2026) 5.2.3 Global Melatonine Price Forecast by Application (2021-2026) 6 North America6.1 North America Melatonine by Country 6.1.1 North America Melatonine Sales by Country 6.1.2 North America Melatonine Revenue by Country 6.1.3 U.S. 6.1.4 Canada6.2 North America Melatonine Market Facts & Figures by Type6.3 North America Melatonine Market Facts & Figures by Application 7 Europe7.1 Europe Melatonine by Country 7.1.1 Europe Melatonine Sales by Country 7.1.2 Europe Melatonine Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia7.2 Europe Melatonine Market Facts & Figures by Type7.3 Europe Melatonine Market Facts & Figures by Application 8 Asia Pacific8.1 Asia Pacific Melatonine by Region 8.1.1 Asia Pacific Melatonine Sales by Region 8.1.2 Asia Pacific Melatonine Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam8.2 Asia Pacific Melatonine Market Facts & Figures by Type8.3 Asia Pacific Melatonine Market Facts & Figures by Application 9 Latin America9.1 Latin America Melatonine by Country 9.1.1 Latin America Melatonine Sales by Country 9.1.2 Latin America Melatonine Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina9.2 Central & South America Melatonine Market Facts & Figures by Type9.3 Central & South America Melatonine Market Facts & Figures by Application 10 Middle East and Africa10.1 Middle East and Africa Melatonine by Country 10.1.1 Middle East and Africa Melatonine Sales by Country 10.1.2 Middle East and Africa Melatonine Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 UAE10.2 Middle East and Africa Melatonine Market Facts & Figures by Type10.3 Middle East and Africa Melatonine Market Facts & Figures by Application 11 Company Profiles11.1 Life Extension 11.1.1 Life Extension Corporation Information 11.1.2 Life Extension Description, Business Overview and Total Revenue 11.1.3 Life Extension Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Life Extension Melatonine Products Offered 11.1.5 Life Extension Recent Development11.2 Pharmavite 11.2.1 Pharmavite Corporation Information 11.2.2 Pharmavite Description, Business Overview and Total Revenue 11.2.3 Pharmavite Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Pharmavite Melatonine Products Offered 11.2.5 Pharmavite Recent Development11.3 NOW Foods 11.3.1 NOW Foods Corporation Information 11.3.2 NOW Foods Description, Business Overview and Total Revenue 11.3.3 NOW Foods Sales, Revenue and Gross Margin (2015-2020) 11.3.4 NOW Foods Melatonine Products Offered 11.3.5 NOW Foods Recent Development11.4 Source Naturals 11.4.1 Source Naturals Corporation Information 11.4.2 Source Naturals Description, Business Overview and Total Revenue 11.4.3 Source Naturals Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Source Naturals Melatonine Products Offered 11.4.5 Source Naturals Recent Development11.5 BY-HEALTH 11.5.1 BY-HEALTH Corporation Information 11.5.2 BY-HEALTH Description, Business Overview and Total Revenue 11.5.3 BY-HEALTH Sales, Revenue and Gross Margin (2015-2020) 11.5.4 BY-HEALTH Melatonine Products Offered 11.5.5 BY-HEALTH Recent Development11.6 GNC 11.6.1 GNC Corporation Information 11.6.2 GNC Description, Business Overview and Total Revenue 11.6.3 GNC Sales, Revenue and Gross Margin (2015-2020) 11.6.4 GNC Melatonine Products Offered 11.6.5 GNC Recent Development11.7 Centrum 11.7.1 Centrum Corporation Information 11.7.2 Centrum Description, Business Overview and Total Revenue 11.7.3 Centrum Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Centrum Melatonine Products Offered 11.7.5 Centrum Recent Development11.8 Jamieson Vitamins 11.8.1 Jamieson Vitamins Corporation Information 11.8.2 Jamieson Vitamins Description, Business Overview and Total Revenue 11.8.3 Jamieson Vitamins Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Jamieson Vitamins Melatonine Products Offered 11.8.5 Jamieson Vitamins Recent Development11.9 Nutraceutical Corporation 11.9.1 Nutraceutical Corporation Corporation Information 11.9.2 Nutraceutical Corporation Description, Business Overview and Total Revenue 11.9.3 Nutraceutical Corporation Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Nutraceutical Corporation Melatonine Products Offered 11.9.5 Nutraceutical Corporation Recent Development11.10 Haviland Enterprises Inc. 11.10.1 Haviland Enterprises Inc. Corporation Information 11.10.2 Haviland Enterprises Inc. Description, Business Overview and Total Revenue 11.10.3 Haviland Enterprises Inc. Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Haviland Enterprises Inc. Melatonine Products Offered 11.10.5 Haviland Enterprises Inc. Recent Development11.1 Life Extension 11.1.1 Life Extension Corporation Information 11.1.2 Life Extension Description, Business Overview and Total Revenue 11.1.3 Life Extension Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Life Extension Melatonine Products Offered 11.1.5 Life Extension Recent Development11.12 AIE Pharmaceuticals 11.12.1 AIE Pharmaceuticals Corporation Information 11.12.2 AIE Pharmaceuticals Description, Business Overview and Total Revenue 11.12.3 AIE Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.12.4 AIE Pharmaceuticals Products Offered 11.12.5 AIE Pharmaceuticals Recent Development11.13 Gemini Pharmaceuticals 11.13.1 Gemini Pharmaceuticals Corporation Information 11.13.2 Gemini Pharmaceuticals Description, Business Overview and Total Revenue 11.13.3 Gemini Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.13.4 Gemini Pharmaceuticals Products Offered 11.13.5 Gemini Pharmaceuticals Recent Development11.14 Spectrum Chemical Mfg. Corp. 11.14.1 Spectrum Chemical Mfg. Corp. Corporation Information 11.14.2 Spectrum Chemical Mfg. Corp. Description, Business Overview and Total Revenue 11.14.3 Spectrum Chemical Mfg. Corp. Sales, Revenue and Gross Margin (2015-2020) 11.14.4 Spectrum Chemical Mfg. Corp. Products Offered 11.14.5 Spectrum Chemical Mfg. Corp. Recent Development11.15 Nutritional Supplement Manufacturers Inc. 11.15.1 Nutritional Supplement Manufacturers Inc. Corporation Information 11.15.2 Nutritional Supplement Manufacturers Inc. Description, Business Overview and Total Revenue 11.15.3 Nutritional Supplement Manufacturers Inc. Sales, Revenue and Gross Margin (2015-2020) 11.15.4 Nutritional Supplement Manufacturers Inc. Products Offered 11.15.5 Nutritional Supplement Manufacturers Inc. Recent Development11.16 Van Wankum Ingredients 11.16.1 Van Wankum Ingredients Corporation Information 11.16.2 Van Wankum Ingredients Description, Business Overview and Total Revenue 11.16.3 Van Wankum Ingredients Sales, Revenue and Gross Margin (2015-2020) 11.16.4 Van Wankum Ingredients Products Offered 11.16.5 Van Wankum Ingredients Recent Development11.17 Action Labs Inc. 11.17.1 Action Labs Inc. Corporation Information 11.17.2 Action Labs Inc. Description, Business Overview and Total Revenue 11.17.3 Action Labs Inc. Sales, Revenue and Gross Margin (2015-2020) 11.17.4 Action Labs Inc. Products Offered 11.17.5 Action Labs Inc. Recent Development11.18 Softgel Nutraceuticals 11.18.1 Softgel Nutraceuticals Corporation Information 11.18.2 Softgel Nutraceuticals Description, Business Overview and Total Revenue 11.18.3 Softgel Nutraceuticals Sales, Revenue and Gross Margin (2015-2020) 11.18.4 Softgel Nutraceuticals Products Offered 11.18.5 Softgel Nutraceuticals Recent Development11.19 Norquay Technology Inc. 11.19.1 Norquay Technology Inc. Corporation Information 11.19.2 Norquay Technology Inc. Description, Business Overview and Total Revenue 11.19.3 Norquay Technology Inc. Sales, Revenue and Gross Margin (2015-2020) 11.19.4 Norquay Technology Inc. Products Offered 11.19.5 Norquay Technology Inc. Recent Development11.20 Arnet Pharmaceutical 11.20.1 Arnet Pharmaceutical Corporation Information 11.20.2 Arnet Pharmaceutical Description, Business Overview and Total Revenue 11.20.3 Arnet Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.20.4 Arnet Pharmaceutical Products Offered 11.20.5 Arnet Pharmaceutical Recent Development11.21 Twinlab Corp. 11.21.1 Twinlab Corp. Corporation Information 11.21.2 Twinlab Corp. Description, Business Overview and Total Revenue 11.21.3 Twinlab Corp. Sales, Revenue and Gross Margin (2015-2020) 11.21.4 Twinlab Corp. Products Offered 11.21.5 Twinlab Corp. Recent Development11.22 Superior Supplement Manufacturing 11.22.1 Superior Supplement Manufacturing Corporation Information 11.22.2 Superior Supplement Manufacturing Description, Business Overview and Total Revenue 11.22.3 Superior Supplement Manufacturing Sales, Revenue and Gross Margin (2015-2020) 11.22.4 Superior Supplement Manufacturing Products Offered 11.22.5 Superior Supplement Manufacturing Recent Development11.23 The Chemical Co. 11.23.1 The Chemical Co. Corporation Information 11.23.2 The Chemical Co. Description, Business Overview and Total Revenue 11.23.3 The Chemical Co. Sales, Revenue and Gross Margin (2015-2020) 11.23.4 The Chemical Co. Products Offered 11.23.5 The Chemical Co. Recent Development 12 Future Forecast by Regions (Countries) (2021-2026)12.1 Melatonine Market Estimates and Projections by Region 12.1.1 Global Melatonine Sales Forecast by Regions 2021-2026 12.1.2 Global Melatonine Revenue Forecast by Regions 2021-202612.2 North America Melatonine Market Size Forecast (2021-2026) 12.2.1 North America: Melatonine Sales Forecast (2021-2026) 12.2.2 North America: Melatonine Revenue Forecast (2021-2026) 12.2.3 North America: Melatonine Market Size Forecast by Country (2021-2026)12.3 Europe Melatonine Market Size Forecast (2021-2026) 12.3.1 Europe: Melatonine Sales Forecast (2021-2026) 12.3.2 Europe: Melatonine Revenue Forecast (2021-2026) 12.3.3 Europe: Melatonine Market Size Forecast by Country (2021-2026)12.4 Asia Pacific Melatonine Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Melatonine Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Melatonine Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Melatonine Market Size Forecast by Region (2021-2026)12.5 Latin America Melatonine Market Size Forecast (2021-2026) 12.5.1 Latin America: Melatonine Sales Forecast (2021-2026) 12.5.2 Latin America: Melatonine Revenue Forecast (2021-2026) 12.5.3 Latin America: Melatonine Market Size Forecast by Country (2021-2026)12.6 Middle East and Africa Melatonine Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Melatonine Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Melatonine Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Melatonine Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis13.1 Market Opportunities and Drivers13.2 Market Challenges13.3 Market Risks/Restraints13.4 Porters Five Forces Analysis13.5 Primary Interviews with Key Melatonine Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis14.1 Value Chain Analysis14.2 Melatonine Customers14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source16.2 Author Details16.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

See more here:
COVID-19 Impact on Melatonine Market Research Report: Probable Key Development To Be Observed Market States And Outlook Across By 2026 - News Distinct

S-adenosylmethionine (SAM-e) Market Production, Revenue And Status forecast 2020 to 2026 – News Collective

The S-adenosylmethionine (SAM-e) Market an off-the-shelf research report for the year 2020-2026 has been recently added by Market Insights Reports to get an in-depth analysis of different attributes of industries and providing timely access to accurate, reliable and unbiased analysis of the market. The data provided related to the Market Size in value and volume*, top market segments driving sales and revenue, top companies, the share of the market in the market and the top countries which account for the maximum production and consumption.

The major manufacturers covered in this report:

Doctors Best, NutraLife, Jarrow Formulas, Now Foods, Life Extension, Source Naturals, California Gold Nutrition, Metabolic Maintenanc, and Others.

We aimed to provide most segmented consumption and sales data of different types of S-adenosylmethionine (SAM-e), downstream consumption fields and competitive landscape in different regions and countries around the world, this report analyzes the latest market data from the primary and secondary authoritative source.

Types Of Global S-adenosylmethionine (SAM-e) Market is Segmented as Follows:

Chemical Synthesis

Fermentation

Enzymatic Conversion

and others.

Sample PDF Copy of S-adenosylmethionine (SAM-e) Market 2019 :

https://www.marketinsightsreports.com/reports/06022058996/covid-19-impact-on-global-s-adenosylmethionine-sam-e-market-insights-forecast-to-2026/inquiry?mode=MH82

Application Of Global S-adenosylmethionine (SAM-e) Market is Segmented as Follows:

Scientific Research

Clinical Treatment

Others

and others.

We aim to deliver a high quality report with a relatively low cost thus delivering a optimum ROI and helping those involved in making informed, analytically driven decisions. Each of our reports has a database that has been researched and honed for the past 5 to 7 years, Along with this secondary sources referred to and studied include press releases, financial statements, analyst reports and other paid sources.

Special Offer: Avail Up to 20% Discount On S-adenosylmethionine (SAM-e) Report:

https://www.marketinsightsreports.com/reports/06022058996/covid-19-impact-on-global-s-adenosylmethionine-sam-e-market-insights-forecast-to-2026/discount?mode=MH82

Geographical Regional Analysis :

The research mainly covers S-adenosylmethionine (SAM-e) market in

-North America (United States, Canada and Mexico)

-Europe industry (Germany, France, UK, Russia and Italy)

-Asia-Pacific (Southeast Asia, China, Korea, India and Japan)

-South America industry (Brazil, Argentina, Colombia)

-Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Important Features that are under Offering and Key Highlights of the Reports:

-Detailed overview of S-adenosylmethionine (SAM-e) Market

-Changing market dynamics of the industry

-In-depth market segmentation by Type, Application etc.

-Historical, current and projected market size in terms of volume and value

-Recent industry trends and developments

-Competitive landscape of S-adenosylmethionine (SAM-e) Plant Market

-Strategies of key players and product offerings

-Potential and niche segments/regions exhibiting promising growth

This data is provided from 2014 to 2019 in actual and has been forecasted from 2020 to 2025 keeping in mind the current market trends, micro and macroeconomic factors and other legal and environmental factors affecting the market.

Buy complete S-adenosylmethionine (SAM-e) Market report at :

https://www.marketinsightsreports.com/reports/06022058996/covid-19-impact-on-global-s-adenosylmethionine-sam-e-market-insights-forecast-to-2026?mode=MH82

We also offer customization on reports based on specific client requirement:

1- Country level analysis for any 5 countries of your choice.

2- Competitive analysis of any 5 key market players.

3- 40 analyst hours to cover any other data points

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights ReportPhone: + 1704 266 3234 | +91-750-707-8687sales@marketinsightsreports.com | irfan@marketinsightsreports.com

See original here:
S-adenosylmethionine (SAM-e) Market Production, Revenue And Status forecast 2020 to 2026 - News Collective

At a budgetary crossroads, the US Navy’s aviation wing must choose between old and new – DefenseNews.com

WASHINGTON In the coming years, the U.S. Navy will be faced with a decision that will radically shape the carrier air wing: Is the service willing to sacrifice dozens of new Super Hornet jets for the promise of a sixth-generation fighter in the 2030s?

The Navy is opting to buy a final 24 F/A-18E/Fs in fiscal 2021, slashing a planned purchase of at least 36 Super Hornets that would have spanned FY22 through FY24. The move will save $4.5 billion, which the service plans to redirect to its sixth-generation fighter program, known as Next Generation Air Dominance, or F/A-XX.

However, the decision may not be as clear cut or final as budget documents make it seem.

The Navy is at the very start of the NGAD development process, having completed an analysis of alternatives in June 2019, as well as broad requirements and guidance for a concept of operations. The effort is now in the concept development phase, during which defense companies explore ideas that balance advanced air dominance capabilities and long-term affordability/sustainment, said Navy spokesman Capt. Danny Hernandez.

But with an economic downturn potentially leading to even more pressure on the defense budget, the Navy may not have the funds to proceed with NGAD as a clean-sheet fighter jet.

Although the Navy would like to start developing the next generation of aircraft ... I just dont think and increasingly people in the department are thinking theres not going to be the money to devote to this next generation of fighter, said Bryan Clark, an analyst with the Hudson Institute and a retired naval officer.

I think they are going to fall back to looking at F/A-XX as a modification or an evolution of the F-35, he said. Instead of the other half of the air wing being some new aircraft, youll have a combination of F-35Cs and then some modified version of the F-35 or a modified Super Hornet."

Sign up for our Early Bird Brief Get the defense industry's most comprehensive news and information straight to your inbox

Subscribe

Enter a valid email address (please select a country) United States United Kingdom Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, The Democratic Republic of The Cook Islands Costa Rica Cote D'ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory, Occupied Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Timor-leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe

Thanks for signing up!

By giving us your email, you are opting in to the Early Bird Brief.

Jerry Hendrix, a retired Navy captain and an analyst with the Telemus Group, said the services enthusiasm for F/A-XX is a sign of a continued preference for manned aviation as well as a desire to shut out any hope of fielding a long-range, penetrating strike drone.

Ive always been in favor of extending the Hornet production line because it is solid and stable, Hendrix said. But the extension was based on the proviso that were extending in order to get to an unmanned combat aerial vehicle. If it was an extension to get to the next manned fighter were missing the idea of what the future competitive environment, or really the present competitive environment, is all about.

The Navy has grappled in prior years with the question of whether to cease production of the Super Hornet in favor of a future fighter, and it is an argument that lawmakers are wary of.

The Navy first planned to stop buying the F/A-18 in its FY15 budget a decision made to fund the transition to the F-35. But technical issues and delays pushed out the fielding of the Navys F-35C takeoff-and-landing model for aircraft carriers to 2018, leaving the service dependent on a fleet of aging, battle-worn F/A-18s in need of a service-life extension. The Navy ended up listing the F/A-18 on its unfunded priorities list, and Congress followed by funding enough Super Hornets to keep Boeings line running.

If we go back a few years and we look at what happened when we thought we were going to plant the F-35, we let the F-18 slide down, Rep. Donald Norcross, D-N.J., said in a March 10 hearing. Norcross is the chairman of the House Subcommittee on Tactical Air and Land Forces.

The process of standing up the F-35C was much slower than expected, and the Navy ended up buying additional F/A-18s to bridge the capability gap, he said. Yet, here we are getting ready to curtail 36 Super Hornets because we are expecting, you know, the F/A-XX to come online, he added.

Asked how he could be confident that F/A-XX would stay on schedule, Rear Adm. Gregory Harris, the Navys director of air warfare, said he could provide lawmakers a more detailed defense of the Navys Next Generation Air Dominance family of systems in a classified setting.

Were working closely with the Air Force to ensure the systems that we put on that have the [technology readiness level] that gives us confidence that we can achieve that aircraft on time in the early 2030s to replace the F/A-18E/F as it reaches the end of its service life, Harris said.

Missouri Rep. Vicky Hartzler, the subcommittees top Republican, pointed out that the Navy already has a fighter shortfall of about 49 aircraft, with additional F/A-18s being pulled from the operational fleet into a service-life extension period that will take at least a year.

I feel like this is too much operational risk, she said. If you add all those up, this is a severe shortage that we are experiencing, and if you dont account for the attrition rate, actually in combat we would have a very large gap there potentially.

James Geurts, the Navys assistant secretary for research, development and acquisition, said there is always risk when transitioning from legacy to new aircraft, but that improved mission-capable rates and a steady flow of jets moving through upgrades will help balance the shortfall.

Were taking risk until the late 2020s. I think 2029 is when we will get to the full fighter inventory, and so we had to take some risk as we balance that, he said.

The most likely scenario is that, as the Navy presses forward with its plan to curtail funding for F/A-18s, Congress will simply continue buying more of them, Hendrix said.

But one unanswered question is whether lawmakers will also intervene to force the Navy to consider a wider range of aviation options that could give the carrier air wing longer legs.

Im hopeful that there will be a broader conversation, led by Congress and the administration, perhaps together, to say: We are looking at the future security environment. We are looking at the Chinese threat. We are looking at whats happening in Taiwan, whats happening [in] Hong Kong and within the first island chain, and we really need to have this new capability of long-range, penetrating strike, Hendrix said.

What I do realize is that because the Navy is very conservative right now in how its approaching its procurement programs, the Navy will not be the one to say we need this mission.

No matter what the Navy decides, it could impact its procurement of the MQ-25 unmanned tanker drone currently under development by Boeing. Hendrix sees the MQ-25 program as a likely bill payer, particularly if the service continues to buy Hornets.

What was the reason for the MQ-25? It was to take the strain off from the Hornets, which were being used to refuel other F/A-18s and burning through their service lives faster than anticipated, Hendrix said. When you reopen the Hornet production line and you add 120-something new Hornets, you actually took that strain off the Hornet fleet. So there really isnt a requirement now for a recovery tanker.

Clark agrees that the Navy should develop a long-range unmanned combat aircraft but is unlikely to do so.

But should the Navy choose not to proceed with an F/A-XX program, Clark believes the service could funnel some of that money into modifying the MQ-25 to supplement strike, intelligence, surveillance and reconnaissance capacities, and could even end buy more MQ-25s than planned.

The MQ-25 program, once it gets fielded and proven out, I could see the Navy expanding it, he said. I think the operational and programmatic pressures have driven the Navy to embrace the MQ-25, and because its a complement to the manned aircraft, its generated less resentment among the manned aviation community.

See the original post here:
At a budgetary crossroads, the US Navy's aviation wing must choose between old and new - DefenseNews.com

Eye Health Supplements Market 2020 Growth by Opportunities, Application, Driver, Current Trends and Forecast by 2026 – Cole of Duty

CMI published a business research report on Eye Health Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20202026. Eye Health Supplements Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.

The global Eye Health Supplements Market analysis further provides pioneering landscape of market along with market augmentation history and key development involved in the industry. The report also features comprehensive research study for high growth potential industries professional survey with market analysis. Eye Health Supplements Market report helps the companies to understand the market trends and future market prospective,opportunities and articulate the critical business strategies.

We do provide Sample of this report, Please go through the following information in order to request Sample Copy

This Report Sample Includes

Receive Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/3791

Geographical segmentation of Eye Health Supplements Market involves the regional outlook which further covers United States, China, Europe, Japan, Southeast Asia and Middle East & Africa. This report categorizes the market based on manufacturers, regions, type and application.

Eye Health Supplements Market: Competitive Landscape

Leading players operating in the global Eye Health Supplements Market include:Bausch + Lomb, Vitabiotics Ltd., Valeant Pharmaceuticals International Inc., Life Extension, Pfizer Inc., OmniActive Health Technologies, Algatechnologies, Alliance Pharma, The Natures Bounty Co., Novartis AG, and Amway Corp.

Scope of the Report

The key features of the Eye Health Supplements Market report 2019-2026 are the organization, extensive amount of analysis and data from previous and current years as well as forecast data for the next five years. Most of the report is made up from tables, charts and figures that give our clients a clear picture of the Eye Health Supplements Market. The structure of Eye Health Supplements Market by identifying its various segments and sub-segments to help understanding the report.

Eye Health Supplements Market Research Report gives current competitive analysis and also valuable insights to clients/industries, which will assist them to prepare a new strategy to expand or penetrate in a global Eye Health Supplements Market.

As the report proceeds further, it covers the analysis of key market participants paired with development plans and policies, production techniques, price structure of the Eye Health Supplements Market. The report also identifies the other essential elements such as product overview, supply chain relationship, raw material supply and demand statistics, expected developments, profit and consumption ratio.

The PDF Research only provides Table of Contents (ToC), scope of the report and research framework of the report.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3791

Important Eye Health Supplements Market Data Available In This Report:

Note: Request Discount option enables you to get the discounts on the actual price of the report. Kindly fill the form, and one of our consultants would get in touch with you to discuss your allocated budget, and would provide discounts.

Use QUARANTINEDAYS Code In Precise Requirement And Get FLAT $1,000 OFF On This Reports

Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/3791

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email:[emailprotected]

For More Related Reports:http://bit.ly/Rajkumar123

Read this article:
Eye Health Supplements Market 2020 Growth by Opportunities, Application, Driver, Current Trends and Forecast by 2026 - Cole of Duty

Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, Market Size, Share, Growth, Trends and Forecast 2026 by Top Manufacturers, Instruments…

Los Angeles, United State: Complete study of the global Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, industry. Research techniques like PESTLE and Porters Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.

The research study includes great insights about critical market dynamics, including drivers, restraints, trends, and opportunities. It also includes various types of market analysis such as competitive analysis, manufacturing cost analysis, manufacturing process analysis, price analysis, and analysis of market influence factors. It is a complete study on the global Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, market that can be used as a set of effective guidelines for ensuring strong growth in the coming years. It caters to all types of interested parties, viz. stakeholders, market participants, investors, market researchers, and other individuals associated with the Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, business.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)https://www.qyresearch.com/sample-form/form/1702900/impact-of-covid-19-outbreak-on-milk-thistle-health-tonic-global-market

It is important for every market participant to be familiar with the competitive scenario in the global Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key Players Mentioned in the Global Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, Market Research Report: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Milk Thistle Health Tonic market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Milk Thistle Health Tonic industry. Prior to COVID-19, the global market for Milk Thistle Health Tonic was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 20212026, whereas post-COVID-19 scenario, the market for Milk Thistle Health Tonic is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 20212026. QY Research has recently curated a research report titled, Global Milk Thistle Health Tonic Market Research Report 2020. The report is structured on primary and secondary research methodologies that derive historic and forecast data. The global Milk Thistle Health Tonic market is growing remarkably fast and is likely to thrive in terms of volume and revenue during the forecast period. Readers can gain insight into the various opportunities and restraints shaping the market. The report demonstrates the progress and bends that will occur during the forecast period. Global Milk Thistle Health Tonic Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the markets growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of sales about the global market and also about each type from 2015 to 2026. This section mentions the volume of sales by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026. A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market experts opinions have been taken to understand the market better. Global Milk Thistle Health Tonic Market: Segment Analysis The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Global Milk Thistle Health Tonic Market: Regional Analysis The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Milk Thistle Health Tonic Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. Following are the segments covered by the report are:, Tablets, Capsules, Others By Application:, Dietary Supplement, Health Food Key Players: The Key manufacturers that are operating in the global Milk Thistle Health Tonic market are:, Health Genesis, Pure Encapsulations, Regis, Solgar, Aksuvital, BEC, NC, Life Extension, Swisse, HerbsofGold Competitive Landscape The analysts have provided a comprehensive analysis of the competitive landscape of the global Milk Thistle Health Tonic market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

Global Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, Market Segmentation by Product:Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Milk Thistle Health Tonic market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Milk Thistle Health Tonic industry. Prior to COVID-19, the global market for Milk Thistle Health Tonic was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 20212026, whereas post-COVID-19 scenario, the market for Milk Thistle Health Tonic is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 20212026. QY Research has recently curated a research report titled, Global Milk Thistle Health Tonic Market Research Report 2020. The report is structured on primary and secondary research methodologies that derive historic and forecast data. The global Milk Thistle Health Tonic market is growing remarkably fast and is likely to thrive in terms of volume and revenue during the forecast period. Readers can gain insight into the various opportunities and restraints shaping the market. The report demonstrates the progress and bends that will occur during the forecast period. Global Milk Thistle Health Tonic Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the markets growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of sales about the global market and also about each type from 2015 to 2026. This section mentions the volume of sales by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026. A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market experts opinions have been taken to understand the market better. Global Milk Thistle Health Tonic Market: Segment Analysis The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Global Milk Thistle Health Tonic Market: Regional Analysis The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Milk Thistle Health Tonic Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. Following are the segments covered by the report are:, Tablets, Capsules, Others By Application:, Dietary Supplement, Health Food Key Players: The Key manufacturers that are operating in the global Milk Thistle Health Tonic market are:, Health Genesis, Pure Encapsulations, Regis, Solgar, Aksuvital, BEC, NC, Life Extension, Swisse, HerbsofGold Competitive Landscape The analysts have provided a comprehensive analysis of the competitive landscape of the global Milk Thistle Health Tonic market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

Global Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, Market Segmentation by Application: Dietary Supplement, Health Food Key Players: The Key manufacturers that are operating in the global Milk Thistle Health Tonic market are:, Health Genesis, Pure Encapsulations, Regis, Solgar, Aksuvital, BEC, NC, Life Extension, Swisse, HerbsofGold Competitive Landscape The analysts have provided a comprehensive analysis of the competitive landscape of the global Milk Thistle Health Tonic market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

The report has classified the global Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, industry.

Additionally, the industry analysts have studied key regions including North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, along with their respective countries. Here, they have given a clear-cut understanding of the present and future situations of the global Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, industry in key regions. This will help the key players to focus on the lucrative regional markets.

Key questions answered in the report:

Request for customization in Report:https://www.qyresearch.com/customize-request/form/1702900/impact-of-covid-19-outbreak-on-milk-thistle-health-tonic-global-market

Table od Content

1 Milk Thistle Health Tonic Market Overview1.1 Product Overview and Scope of Milk Thistle Health Tonic1.2 Covid-19 Implications on Milk Thistle Health Tonic Segment by Type1.2.1 Global Milk Thistle Health Tonic Sales Growth Rate Comparison by Type (2021-2026)1.2.2 Tablets1.2.3 Capsules1.2.4 Others1.3 Covid-19 Implications on Milk Thistle Health Tonic Segment by Application1.3.1 Milk Thistle Health Tonic Sales Comparison by Application: 2020 VS 20261.3.2 Dietary Supplement1.3.3 Health Food1.4 Covid-19 Implications on Global Milk Thistle Health Tonic Market Size Estimates and Forecasts1.4.1 Global Milk Thistle Health Tonic Revenue 2015-20261.4.2 Global Milk Thistle Health Tonic Sales 2015-20261.4.3 Milk Thistle Health Tonic Market Size by Region: 2020 Versus 20261.5 Coronavirus Disease 2019 (Covid-19): Milk Thistle Health Tonic Industry Impact1.5.1 How the Covid-19 is Affecting the Milk Thistle Health Tonic Industry1.5.1.1 Milk Thistle Health Tonic Business Impact Assessment Covid-191.5.1.2 Supply Chain Challenges1.5.1.3 COVID-19s Impact On Crude Oil and Refined Products1.5.2 Market Trends and Milk Thistle Health Tonic Potential Opportunities in the COVID-19 Landscape1.5.3 Measures / Proposal against Covid-191.5.3.1 Government Measures to Combat Covid-19 Impact1.5.3.2 Proposal for Milk Thistle Health Tonic Players to Combat Covid-19 Impact 2 Covid-19 Implications on Global Milk Thistle Health Tonic Market Competition by Manufacturers2.1 Global Milk Thistle Health Tonic Sales Market Share by Manufacturers (2015-2020)2.2 Global Milk Thistle Health Tonic Revenue Share by Manufacturers (2015-2020)2.3 Global Milk Thistle Health Tonic Average Price by Manufacturers (2015-2020)2.4 Manufacturers Milk Thistle Health Tonic Manufacturing Sites, Area Served, Product Type2.5 Milk Thistle Health Tonic Market Competitive Situation and Trends2.5.1 Milk Thistle Health Tonic Market Concentration Rate2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)2.6 Manufacturers Mergers & Acquisitions, Expansion Plans2.7 Primary Interviews with Key Milk Thistle Health Tonic Players (Opinion Leaders) 3 Covid-19 Implications on Milk Thistle Health Tonic Retrospective Market Scenario by Region3.1 Global Milk Thistle Health Tonic Retrospective Market Scenario in Sales by Region: 2015-20203.2 Global Milk Thistle Health Tonic Retrospective Market Scenario in Revenue by Region: 2015-20203.3 North America Milk Thistle Health Tonic Market Facts & Figures by Country3.3.1 North America Milk Thistle Health Tonic Sales by Country3.3.2 North America Milk Thistle Health Tonic Sales by Country3.3.3 U.S.3.3.4 Canada3.4 Europe Milk Thistle Health Tonic Market Facts & Figures by Country3.4.1 Europe Milk Thistle Health Tonic Sales by Country3.4.2 Europe Milk Thistle Health Tonic Sales by Country3.4.3 Germany3.4.4 France3.4.5 U.K.3.4.6 Italy3.4.7 Russia3.5 Asia Pacific Milk Thistle Health Tonic Market Facts & Figures by Region3.5.1 Asia Pacific Milk Thistle Health Tonic Sales by Region3.5.2 Asia Pacific Milk Thistle Health Tonic Sales by Region3.5.3 China3.5.4 Japan3.5.5 South Korea3.5.6 India3.5.7 Australia3.5.8 Taiwan3.5.9 Indonesia3.5.10 Thailand3.5.11 Malaysia3.5.12 Philippines3.5.13 Vietnam3.6 Latin America Milk Thistle Health Tonic Market Facts & Figures by Country3.6.1 Latin America Milk Thistle Health Tonic Sales by Country3.6.2 Latin America Milk Thistle Health Tonic Sales by Country3.6.3 Mexico3.6.3 Brazil3.6.3 Argentina3.7 Middle East and Africa Milk Thistle Health Tonic Market Facts & Figures by Country3.7.1 Middle East and Africa Milk Thistle Health Tonic Sales by Country3.7.2 Middle East and Africa Milk Thistle Health Tonic Sales by Country3.7.3 Turkey3.7.4 Saudi Arabia3.7.5 U.A.E 4 Global Milk Thistle Health Tonic Historic Market Analysis by Type4.1 Global Milk Thistle Health Tonic Sales Market Share by Type (2015-2020)4.2 Global Milk Thistle Health Tonic Revenue Market Share by Type (2015-2020)4.3 Global Milk Thistle Health Tonic Price Market Share by Type (2015-2020)4.4 Global Milk Thistle Health Tonic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Milk Thistle Health Tonic Historic Market Analysis by Application5.1 Global Milk Thistle Health Tonic Sales Market Share by Application (2015-2020)5.2 Global Milk Thistle Health Tonic Revenue Market Share by Application (2015-2020)5.3 Global Milk Thistle Health Tonic Price by Application (2015-2020) 6 Company Profiles and Key Figures in Milk Thistle Health Tonic Business6.1 Health Genesis6.1.1 Corporation Information6.1.2 Health Genesis Description, Business Overview and Total Revenue6.1.3 Health Genesis Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.1.4 Health Genesis Products Offered6.1.5 Health Genesis Recent Development6.2 Pure Encapsulations6.2.1 Pure Encapsulations Corporation Information6.2.2 Pure Encapsulations Description, Business Overview and Total Revenue6.2.3 Pure Encapsulations Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.2.4 Pure Encapsulations Products Offered6.2.5 Pure Encapsulations Recent Development6.3 Regis6.3.1 Regis Corporation Information6.3.2 Regis Description, Business Overview and Total Revenue6.3.3 Regis Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.3.4 Regis Products Offered6.3.5 Regis Recent Development6.4 Solgar6.4.1 Solgar Corporation Information6.4.2 Solgar Description, Business Overview and Total Revenue6.4.3 Solgar Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.4.4 Solgar Products Offered6.4.5 Solgar Recent Development6.5 Aksuvital6.5.1 Aksuvital Corporation Information6.5.2 Aksuvital Description, Business Overview and Total Revenue6.5.3 Aksuvital Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.5.4 Aksuvital Products Offered6.5.5 Aksuvital Recent Development6.6 BEC6.6.1 BEC Corporation Information6.6.2 BEC Description, Business Overview and Total Revenue6.6.3 BEC Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.6.4 BEC Products Offered6.6.5 BEC Recent Development6.7 NC6.6.1 NC Corporation Information6.6.2 NC Description, Business Overview and Total Revenue6.6.3 NC Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.4.4 NC Products Offered6.7.5 NC Recent Development6.8 Life Extension6.8.1 Life Extension Corporation Information6.8.2 Life Extension Description, Business Overview and Total Revenue6.8.3 Life Extension Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.8.4 Life Extension Products Offered6.8.5 Life Extension Recent Development6.9 Swisse6.9.1 Swisse Corporation Information6.9.2 Swisse Description, Business Overview and Total Revenue6.9.3 Swisse Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.9.4 Swisse Products Offered6.9.5 Swisse Recent Development6.10 HerbsofGold6.10.1 HerbsofGold Corporation Information6.10.2 HerbsofGold Description, Business Overview and Total Revenue6.10.3 HerbsofGold Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)6.10.4 HerbsofGold Products Offered6.10.5 HerbsofGold Recent Development 7 Milk Thistle Health Tonic Manufacturing Cost Analysis7.1 Milk Thistle Health Tonic Key Raw Materials Analysis7.1.1 Key Raw Materials7.1.2 Key Raw Materials Price Trend7.1.3 Key Suppliers of Raw Materials7.2 Proportion of Manufacturing Cost Structure7.3 Manufacturing Process Analysis of Milk Thistle Health Tonic7.4 Milk Thistle Health Tonic Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers8.1 Marketing Channel8.2 Milk Thistle Health Tonic Distributors List8.3 Milk Thistle Health Tonic Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porters Five Forces Analysis 10 Global Market Forecast10.1 Global Milk Thistle Health Tonic Market Estimates and Projections by Type10.1.1 Global Forecasted Sales of Milk Thistle Health Tonic by Type (2021-2026)10.1.2 Global Forecasted Revenue of Milk Thistle Health Tonic by Type (2021-2026)10.2 Milk Thistle Health Tonic Market Estimates and Projections by Application10.2.1 Global Forecasted Sales of Milk Thistle Health Tonic by Application (2021-2026)10.2.2 Global Forecasted Revenue of Milk Thistle Health Tonic by Application (2021-2026)10.3 Milk Thistle Health Tonic Market Estimates and Projections by Region10.3.1 Global Forecasted Sales of Milk Thistle Health Tonic by Region (2021-2026)10.3.2 Global Forecasted Revenue of Milk Thistle Health Tonic by Region (2021-2026)10.4 North America Milk Thistle Health Tonic Estimates and Projections (2021-2026)10.5 Europe Milk Thistle Health Tonic Estimates and Projections (2021-2026)10.6 Asia Pacific Milk Thistle Health Tonic Estimates and Projections (2021-2026)10.7 Latin America Milk Thistle Health Tonic Estimates and Projections (2021-2026)10.8 Middle East and Africa Milk Thistle Health Tonic Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

Read more:
Impact of COVID-19 Outbreak on Milk Thistle Health Tonic, Market Size, Share, Growth, Trends and Forecast 2026 by Top Manufacturers, Instruments...

Milk Thistle Health Tonic Market In Depth Research with Industry Driving Factors, Consumer Behaviour Analysis, Future Trends, Key Players and Forecast…

Los Angeles, United State: Complete study of the global Milk Thistle Health Tonic market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Milk Thistle Health Tonic industry. Research techniques like PESTLE and Porters Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Milk Thistle Health Tonic production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.

The research study includes great insights about critical market dynamics, including drivers, restraints, trends, and opportunities. It also includes various types of market analysis such as competitive analysis, manufacturing cost analysis, manufacturing process analysis, price analysis, and analysis of market influence factors. It is a complete study on the global Milk Thistle Health Tonic market that can be used as a set of effective guidelines for ensuring strong growth in the coming years. It caters to all types of interested parties, viz. stakeholders, market participants, investors, market researchers, and other individuals associated with the Milk Thistle Health Tonic business.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)https://www.qyresearch.com/sample-form/form/1703248/global-milk-thistle-health-tonic-market

It is important for every market participant to be familiar with the competitive scenario in the global Milk Thistle Health Tonic industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key Players Mentioned in the Global Milk Thistle Health Tonic Market Research Report: , Health Genesis, Pure Encapsulations, Regis, Solgar, Aksuvital, BEC, NC, Life Extension, Swisse, HerbsofGold

Global Milk Thistle Health Tonic Market Segmentation by Product:, Tablets, Capsules, Others

Global Milk Thistle Health Tonic Market Segmentation by Application: Dietary Supplement, Health Food Health Genesis, Pure Encapsulations, Regis, Solgar, Aksuvital, BEC, NC, Life Extension, Swisse, HerbsofGold

The report has classified the global Milk Thistle Health Tonic industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Milk Thistle Health Tonic manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Milk Thistle Health Tonic industry.

Additionally, the industry analysts have studied key regions including North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, along with their respective countries. Here, they have given a clear-cut understanding of the present and future situations of the global Milk Thistle Health Tonic industry in key regions. This will help the key players to focus on the lucrative regional markets.

Key questions answered in the report:

Request for customization in Report:https://www.qyresearch.com/customize-request/form/1703248/global-milk-thistle-health-tonic-market

Table od Content

1 Milk Thistle Health Tonic Market Overview1.1 Milk Thistle Health Tonic Product Overview1.2 Milk Thistle Health Tonic Market Segment by Type1.2.1 Tablets1.2.2 Capsules1.2.3 Others1.3 Global Milk Thistle Health Tonic Market Size by Type (2015-2026)1.3.1 Global Milk Thistle Health Tonic Market Size Overview by Type (2015-2026)1.3.2 Global Milk Thistle Health Tonic Historic Market Size Review by Type (2015-2020)1.3.2.1 Global Milk Thistle Health Tonic Sales Market Share Breakdown by Type (2015-2026)1.3.2.2 Global Milk Thistle Health Tonic Revenue Market Share Breakdown by Type (2015-2026)1.3.2.3 Global Milk Thistle Health Tonic Average Selling Price (ASP) by Type (2015-2026)1.3.3 Global Milk Thistle Health Tonic Market Size Forecast by Type (2021-2026)1.3.3.1 Global Milk Thistle Health Tonic Sales Market Share Breakdown by Application (2021-2026)1.3.3.2 Global Milk Thistle Health Tonic Revenue Market Share Breakdown by Application (2021-2026)1.3.3.3 Global Milk Thistle Health Tonic Average Selling Price (ASP) by Application (2021-2026)1.4 Key Regions Market Size Segment by Type (2015-2020)1.4.1 North America Milk Thistle Health Tonic Sales Breakdown by Type (2015-2026)1.4.2 Europe Milk Thistle Health Tonic Sales Breakdown by Type (2015-2026)1.4.3 Asia-Pacific Milk Thistle Health Tonic Sales Breakdown by Type (2015-2026)1.4.4 Latin America Milk Thistle Health Tonic Sales Breakdown by Type (2015-2026)1.4.5 Middle East and Africa Milk Thistle Health Tonic Sales Breakdown by Type (2015-2026)1.5 Coronavirus Disease 2019 (Covid-19): Milk Thistle Health Tonic Industry Impact1.5.1 How the Covid-19 is Affecting the Milk Thistle Health Tonic Industry1.5.1.1 Milk Thistle Health Tonic Business Impact Assessment Covid-191.5.1.2 Supply Chain Challenges1.5.1.3 COVID-19s Impact On Crude Oil and Refined Products1.5.2 Market Trends and Milk Thistle Health Tonic Potential Opportunities in the COVID-19 Landscape1.5.3 Measures / Proposal against Covid-191.5.3.1 Government Measures to Combat Covid-19 Impact1.5.3.2 Proposal for Milk Thistle Health Tonic Players to Combat Covid-19 Impact 2 Global Milk Thistle Health Tonic Market Competition by Company2.1 Global Top Players by Milk Thistle Health Tonic Sales (2015-2020)2.2 Global Top Players by Milk Thistle Health Tonic Revenue (2015-2020)2.3 Global Top Players Milk Thistle Health Tonic Average Selling Price (ASP) (2015-2020)2.4 Global Top Manufacturers Milk Thistle Health Tonic Manufacturing Base Distribution, Sales Area, Product Type2.5 Milk Thistle Health Tonic Market Competitive Situation and Trends2.5.1 Milk Thistle Health Tonic Market Concentration Rate (2015-2020)2.5.2 Global 5 and 10 Largest Manufacturers by Milk Thistle Health Tonic Sales and Revenue in 20192.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Milk Thistle Health Tonic as of 2019)2.7 Date of Key Manufacturers Enter into Milk Thistle Health Tonic Market2.8 Key Manufacturers Milk Thistle Health Tonic Product Offered2.9 Mergers & Acquisitions, Expansion 3 Global Milk Thistle Health Tonic Status and Outlook by Region (2015-2026)3.1 Global Milk Thistle Health Tonic Market Size and CAGR by Region: 2015 VS 2020 VS 20263.2 Global Milk Thistle Health Tonic Market Size Market Share by Region (2015-2020)3.2.1 Global Milk Thistle Health Tonic Sales Market Share by Region (2015-2020)3.2.2 Global Milk Thistle Health Tonic Revenue Market Share by Region (2015-2020)3.2.3 Global Milk Thistle Health Tonic Sales, Revenue, Price and Gross Margin (2015-2020)3.3 Global Milk Thistle Health Tonic Market Size Market Share by Region (2021-2026)3.3.1 Global Milk Thistle Health Tonic Sales Market Share by Region (2021-2026)3.3.2 Global Milk Thistle Health Tonic Revenue Market Share by Region (2021-2026)3.3.3 Global Milk Thistle Health Tonic Sales, Revenue, Price and Gross Margin (2021-2026)3.4 North America Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)3.4.1 North America Milk Thistle Health Tonic Revenue YoY Growth (2015-2026)3.4.2 North America Milk Thistle Health Tonic Sales YoY Growth (2015-2026)3.5 Asia-Pacific Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)3.5.1 Asia-Pacific Milk Thistle Health Tonic Revenue YoY Growth (2015-2026)3.5.2 Asia-Pacific Milk Thistle Health Tonic Sales YoY Growth (2015-2026)3.6 Europe Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)3.6.1 Europe Milk Thistle Health Tonic Revenue YoY Growth (2015-2026)3.6.2 Europe Milk Thistle Health Tonic Sales YoY Growth (2015-2026)3.7 Latin America Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)3.7.1 Latin America Milk Thistle Health Tonic Revenue YoY Growth (2015-2026)3.7.2 Latin America Milk Thistle Health Tonic Sales YoY Growth (2015-2026)3.8 Middle East and Africa Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)3.8.1 Middle East and Africa Milk Thistle Health Tonic Revenue YoY Growth (2015-2026)3.8.2 Middle East and Africa Milk Thistle Health Tonic Sales YoY Growth (2015-2026) 4 Global Milk Thistle Health Tonic by Application4.1 Milk Thistle Health Tonic Segment by Application4.1.1 Dietary Supplement4.1.2 Health Food4.2 Global Milk Thistle Health Tonic Sales by Application: 2015 VS 2020 VS 20264.3 Global Milk Thistle Health Tonic Historic Sales by Application (2015-2020)4.4 Global Milk Thistle Health Tonic Forecasted Sales by Application (2021-2026)4.5 Key Regions Milk Thistle Health Tonic Market Size by Application4.5.1 North America Milk Thistle Health Tonic by Application4.5.2 Europe Milk Thistle Health Tonic by Application4.5.3 Asia-Pacific Milk Thistle Health Tonic by Application4.5.4 Latin America Milk Thistle Health Tonic by Application4.5.5 Middle East and Africa Milk Thistle Health Tonic by Application 5 North America Milk Thistle Health Tonic Market Size by Country (2015-2026)5.1 North America Market Size Market Share by Country (2015-2020)5.1.1 North America Milk Thistle Health Tonic Sales Market Share by Country (2015-2020)5.1.2 North America Milk Thistle Health Tonic Revenue Market Share by Country (2015-2020)5.2 North America Market Size Market Share by Country (2021-2026)5.2.1 North America Milk Thistle Health Tonic Sales Market Share by Country (2021-2026)5.2.2 North America Milk Thistle Health Tonic Revenue Market Share by Country (2021-2026)5.3 North America Market Size YoY Growth by Country5.3.1 U.S. Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)5.3.2 Canada Milk Thistle Health Tonic Market Size YoY Growth (2015-2026) 6 Europe Milk Thistle Health Tonic Market Size by Country (2015-2026)6.1 Europe Market Size Market Share by Country (2015-2020)6.1.1 Europe Milk Thistle Health Tonic Sales Market Share by Country (2015-2020)6.1.2 Europe Milk Thistle Health Tonic Revenue Market Share by Country (2015-2020)6.2 Europe Market Size Market Share by Country (2021-2026)6.2.1 Europe Milk Thistle Health Tonic Sales Market Share by Country (2021-2026)6.2.2 Europe Milk Thistle Health Tonic Revenue Market Share by Country (2021-2026)6.3 Europe Market Size YoY Growth by Country6.3.1 Germany Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)6.3.2 France Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)6.3.3 U.K. Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)6.3.4 Italy Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)6.3.5 Russia Milk Thistle Health Tonic Market Size YoY Growth (2015-2026) 7 Asia-Pacific Milk Thistle Health Tonic Market Size by Country (2015-2026)7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)7.1.1 Asia-Pacific Milk Thistle Health Tonic Sales Market Share by Country (2015-2020)7.1.2 Asia-Pacific Milk Thistle Health Tonic Revenue Market Share by Country (2015-2020)7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)7.2.1 Asia-Pacific Milk Thistle Health Tonic Sales Market Share by Country (2021-2026)7.2.2 Asia-Pacific Milk Thistle Health Tonic Revenue Market Share by Country (2021-2026)7.3 Asia-Pacific Market Size YoY Growth by Country7.3.1 China Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.2 Japan Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.3 South Korea Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.4 India Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.5 Australia Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.6 Taiwan Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.7 Indonesia Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.8 Thailand Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.9 Malaysia Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.10 Philippines Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)7.3.11 Vietnam Milk Thistle Health Tonic Market Size YoY Growth (2015-2026) 8 Latin America Milk Thistle Health Tonic Market Size by Country (2015-2026)8.1 Latin America Market Size Market Share by Country (2015-2020)8.1.1 Latin America Milk Thistle Health Tonic Sales Market Share by Country (2015-2020)8.1.2 Latin America Milk Thistle Health Tonic Revenue Market Share by Country (2015-2020)8.2 Latin America Market Size Market Share by Country (2021-2026)8.2.1 Latin America Milk Thistle Health Tonic Sales Market Share by Country (2021-2026)8.2.2 Latin America Milk Thistle Health Tonic Revenue Market Share by Country (2021-2026)8.3 Latin America Market Size YoY Growth by Country8.3.1 Mexico Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)8.3.2 Brazil Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)8.3.3 Argentina Milk Thistle Health Tonic Market Size YoY Growth (2015-2026) 9 Middle East and Africa Milk Thistle Health Tonic Market Size by Country (2015-2026)9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)9.1.1 Middle East and Africa Milk Thistle Health Tonic Sales Market Share by Country (2015-2020)9.1.2 Middle East and Africa Milk Thistle Health Tonic Revenue Market Share by Country (2015-2020)9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)9.2.1 Middle East and Africa Milk Thistle Health Tonic Sales Market Share by Country (2021-2026)9.2.2 Middle East and Africa Milk Thistle Health Tonic Revenue Market Share by Country (2021-2026)9.3 Middle East and Africa Market Size YoY Growth by Country9.3.1 Turkey Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)9.3.2 Saudi Arabia Milk Thistle Health Tonic Market Size YoY Growth (2015-2026)9.3.3 U.A.E Milk Thistle Health Tonic Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in Milk Thistle Health Tonic Business10.1 Health Genesis10.1.1 Health Genesis Corporation Information10.1.2 Health Genesis Description, Business Overview and Total Revenue10.1.3 Health Genesis Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)10.1.4 Health Genesis Milk Thistle Health Tonic Products Offered10.1.5 Health Genesis Recent Development10.2 Pure Encapsulations10.2.1 Pure Encapsulations Corporation Information10.2.2 Pure Encapsulations Description, Business Overview and Total Revenue10.2.3 Pure Encapsulations Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)10.2.4 Health Genesis Milk Thistle Health Tonic Products Offered10.2.5 Pure Encapsulations Recent Development10.3 Regis10.3.1 Regis Corporation Information10.3.2 Regis Description, Business Overview and Total Revenue10.3.3 Regis Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)10.3.4 Regis Milk Thistle Health Tonic Products Offered10.3.5 Regis Recent Development10.4 Solgar10.4.1 Solgar Corporation Information10.4.2 Solgar Description, Business Overview and Total Revenue10.4.3 Solgar Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)10.4.4 Solgar Milk Thistle Health Tonic Products Offered10.4.5 Solgar Recent Development10.5 Aksuvital10.5.1 Aksuvital Corporation Information10.5.2 Aksuvital Description, Business Overview and Total Revenue10.5.3 Aksuvital Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)10.5.4 Aksuvital Milk Thistle Health Tonic Products Offered10.5.5 Aksuvital Recent Development10.6 BEC10.6.1 BEC Corporation Information10.6.2 BEC Description, Business Overview and Total Revenue10.6.3 BEC Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)10.6.4 BEC Milk Thistle Health Tonic Products Offered10.6.5 BEC Recent Development10.7 NC10.7.1 NC Corporation Information10.7.2 NC Description, Business Overview and Total Revenue10.7.3 NC Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)10.7.4 NC Milk Thistle Health Tonic Products Offered10.7.5 NC Recent Development10.8 Life Extension10.8.1 Life Extension Corporation Information10.8.2 Life Extension Description, Business Overview and Total Revenue10.8.3 Life Extension Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)10.8.4 Life Extension Milk Thistle Health Tonic Products Offered10.8.5 Life Extension Recent Development10.9 Swisse10.9.1 Swisse Corporation Information10.9.2 Swisse Description, Business Overview and Total Revenue10.9.3 Swisse Milk Thistle Health Tonic Sales, Revenue and Gross Margin (2015-2020)10.9.4 Swisse Milk Thistle Health Tonic Products Offered10.9.5 Swisse Recent Development10.10 HerbsofGold10.10.1 Company Basic Information, Manufacturing Base and Competitors10.10.2 Milk Thistle Health Tonic Product Category, Application and Specification10.10.3 HerbsofGold Milk Thistle Health Tonic Sales, Revenue, Price and Gross Margin (2015-2020)10.10.4 Main Business Overview10.10.5 HerbsofGold Recent Development 11 Milk Thistle Health Tonic Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 Milk Thistle Health Tonic Key Raw Materials11.1.1 Key Raw Materials11.1.2 Key Raw Materials Price11.1.3 Raw Materials Key Suppliers11.2 Manufacturing Cost Structure11.2.1 Raw Materials11.2.2 Labor Cost11.2.3 Manufacturing Expenses11.3 Milk Thistle Health Tonic Industrial Chain Analysis11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis11.4.1 Market Opportunities and Drivers11.4.2 Market Challenges11.4.3 Market Risks11.4.4 Porters Five Forces Analysis 12 Market Strategy Analysis, Distributors12.1 Sales Channel12.2 Distributors12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Author Details14.4 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

View post:
Milk Thistle Health Tonic Market In Depth Research with Industry Driving Factors, Consumer Behaviour Analysis, Future Trends, Key Players and Forecast...

UK North Sea to dominate global decommissioning spend over next five years – News for the Oil and Gas Sector – Energy Voice

The UK is poised to lead the way as operators increase spending on North Sea decommissioning work amid low oil prices, according to a new report.

Independent research company Rystad Energy has predicted Britain is in line for nearly 80% of the 14billion it estimates could be spent on removal projects in north-west Europe over the next five years.

The researchers said that, with exploration and production budgets slashed since the Covid-19 pandemic took hold and sent oil prices tumbling and few profitable investment alternatives, operators are now likely to increase spending on decommissioning projects.

Rystad estimates the value for the market world-wide may reach 34.5billion by 2024.The report added that, with an average asset age of 25 years, the north-west European decommissioning sector could grow 20% in annual commitments over the next 18 months if the current low oil prices do not show signs of substantial recovery soon.

It continued: In addition to a rapidly maturing asset base and low oil prices that erode commercial viability and potential life extensions, the North Sea decommissioning market will also be helped by favourable service contract prices.

Rystad energy service analyst, Sumit Yadev, said: A protracted low price environment can potentially motivate operators to leverage low contract prices and commit to their asset retirement obligations, thus spurring decommissioning activity in the north-west Europe region.

This will also provide welcome opportunities for contractors in an otherwise gloomy oilfield services market.

The report warned increased spending on decommissioning may limit the room for operators to invest in other segments, including exploration, development and enhanced oil recovery initiatives.

Leading players such as Shell, Total, Repsol and Premier Oil are expected to assign 10% or more of their North Sea spending in the next five years to removal projects.

Only about 15% of North Sea assets have been decommissioned to date, but in its latest report, Rystad Energy predicts an average of 23 assets will cease production annually over the coming five years.

The research firm expects during the next decade operators will carry out the decommissioning of more than 2,500 wells in the sector, of which 1,500 are in the UK Continental Shelf (UKCS) area.

It said nearly 300,000 tonnes of topsides will be removed from the UKCS by 2025, along with almost 100,000 tonnes of substructure.

With around 50 topsides due to be decommissioned, Rystad estimated an average removal cost of more than 4,300 per tonne.

Plugging and abandonment (P&A) of wells is expected to make up about 45% of decommissioning costs over the next five years, followed by platform removals, which will account for nearly 20% of total expenditure.

Platform wells will be the dominant segment for P&A activity, making up about 65% of the total well abandonment, while the rest are subsea wells.

But, in cost terms, subsea wells will take the lead at an average of 9m each to abandon, compared to 4m for a platform well.

Some of the leading assets that will drive the North Sea decommissioning market include the Brent, Ninian and Thistle fields in the UK and Gyda, in Norway.

Shells Brent project would emerge as the single largest asset decommissioned globally, representing an outlay of nearly 2.5bn alone over the coming decade.

Rystad said the current low oil prices could play a pivotal role in boosting decommissioning spending in the UK if they persist beyond the end of this year.

Nearly 10% of all UK offshore assets have lifting costs above 20 per barrel, which will hamper their life extension prospects and make removal a better financial option if low prices continue.

Read more here:
UK North Sea to dominate global decommissioning spend over next five years - News for the Oil and Gas Sector - Energy Voice

Goldstar Insurance and Prudential partner to offer COVID -19 cover – Uganda

Goldstar Insurance and Prudential Uganda have partnered to offer a new insurance cover to offer life insurance cover to Goldstars Workmans Compensation and Group Personal Accident Policyholders.

The new insurance product called COVID19 Group Life Extension Insurance Cover covers groups of individuals of companies and organizations against devastating COViD19 pandemic. It is underwritten by Prudential.

In the new partnership, Prudential shall offer cover against Natural Death to all Goldstar Workmans Compensation and Group Personal Accident Policyholders against death due to natural causes.

Goldstar Insurance said this cover is an extension of your existing Workmans Compensation & Group Personal Accident policy with Goldstar to bridge the gap left out by this class of insurance.

The death benefit enshrined under the traditional workers compensation and group personal accident is only payable if death is due to accidental causes and does not include death due to natural causes including Covid19,

Because of the above shortcoming, Goldstar Insurance has partnered with Prudential Life to offer cover against natural death to all Goldstar and GPA Policy Holders and death due to Covod19 is hereby covered, Goldstar has said.

Meanwhile, Very early on in the COVID 19 crisis, Prudential took the decision to ensure that all their clients, staff, agents and indeed as many Ugandans that might, unfortunately, get diagnosed with Covid-19, are given a cash payout to help their families manage expenses.

This according to Arjun Mallik the Managing Director Prudential East Africa, was to cushion the families with financial assistance as their loved ones get healed from COVID- 19.

BY EABW REPORTER

Related

Read the rest here:
Goldstar Insurance and Prudential partner to offer COVID -19 cover - Uganda

Oil & Gas Decommissioning To Total $42 Billion Through 2024 – OilPrice.com

Energy companies have been slashing exploration and production budgets since the Covid-19 pandemic took hold and sent oil prices tumbling, but, with few profitable investment alternatives, operators are now likely to increase spending in decommissioning work. Rystad Energy estimates the total value of the global pool of decommissioning projects that will accumulate through 2024 could reach $42 billion. With an average asset age of 25 years, the Northwest European decommissioning market could grow 20% in annual commitments through 2022 if the current low oil prices dont show signs of substantial recovery soon. In addition to a rapidly maturing asset base and low oil prices that erode commercial viability and potential life extensions, the North Sea decommissioning market will also be helped by favorable service contract prices.

Only about 15% of North Sea assets have been decommissioned to date, but in the coming five years we expect an average of 23 assets to cease production annually. The UK is poised to lead the way with nearly 80% of total estimated expenditure on Northwest European decommissioning in the next five years, followed by Norway with 14% and Denmark with 4%. The pool of removal projects in the region for that period is estimated at about $17 billion. By comparison, decommissioning costs in the US for the same period are estimated at $5.7 billion.

A protracted low price environment can potentially motivate operators to leverage low contract prices and commit to their asset retirement obligations, thus spurring decommissioning activity in the Northwest Europe region. This will also provide welcome opportunities for contractors in an otherwise gloomy oilfield services market, says Sumit Yadev, energy service analyst at Rystad Energy.

(Click to enlarge)

The high market share of the UK can be largely attributed to its rapidly maturing production levels, as almost 80% of the countrys oil and gas assets have produced more than 75% of their available resources. Additionally, lackluster exploration results, growing regulatory stringency and a prolonged low oil price environment may lead operators to fulfill their asset retirement obligations in the absence of any lucrative competing investments.

Related: Europe Set To Unveil Its $500 Billion 'Green Deal'

Some of the leading assets that will drive the decommissioning market in the region include the Brent, Ninian and Thistle fields in the UK and Gyda in Norway. Shells Brent project would emerge as the single largest asset ever decommissioned globally, representing an outlay of nearly $3 billion alone over the coming decade. Ninian and Gyda would collectively present contracting opportunities worth nearly $2 billion.

The increased spending on decommissioning may limit the room for operators to invest in other segments such as exploration, development and enhanced oil recovery projects. Leading players such as Shell, Total, Repsol and Premier Oil are expected to assign 10% or more of their North Sea spending in the next five years to decommissioning activities.

Plugging and abandonment (P&A) of wells is expected to make up about 45% of decommissioning costs for the period, followed by platform removals, which account for nearly 20% of the total costs. Platform wells are set to be the dominant segment for well P&A activity, making up about 65% of the total wells to be abandoned, while the rest are subsea wells. However, in terms of costs, subsea wells will take the lead as they cost on average $11 million each to abandon, compared with $5 million for an average platform well.

The low oil prices could play a pivotal role in boosting decommissioning spending in the UK if they persist beyond the end of this year. Nearly 10% of all UK offshore assets have lifting costs above $25 per barrel, which will hamper their life extension prospects and make decommissioning a better financial option if low prices persist.

Operators implemented strong cost optimization measures after the oil price crash of 2014 and therefore have little room for further cost and efficiency gains now, which may also expedite decommissioning spending.

Overall, more than 2,500 oil and gas wells are expected to be decommissioned across the North Sea in the coming decade, of which 1,500 are in the UK. The UKCS will also witness the removal of nearly 300,000 tonnes of topsides in the next five years, with nearly 50 topsides set to be decommissioned, representing an average topside removal cost of $5,300 per tonne. Additionally, almost 100,000 tonnes of substructures are expected to be removed in UK waters. In line with the broader North Sea trends, platform wells are expected to account for the bulk of the well P&A activity with nearly 70%.

While decommissioning is becoming a pressing concern for North Sea operators, the prevailing low-price environment presents an opportunity for driving down costs. For instance, after the oil price slump of 2014, rig and vessel rates declined by 30% to 40%. We expect rig and vessel rates to exhibit a downward trend this time as well, with declines likely lasting until 2022, Yadev concludes.

By Rystad Energy

More Top Reads From Oilprice.com:

Here is the original post:
Oil & Gas Decommissioning To Total $42 Billion Through 2024 - OilPrice.com

Humans will be able to replace their bodies within 50 years claims transhumanist writer – Express.co.uk

Transhumanists believe humans can and should use technology to artificially augment their capabilities.Natasha Vita-More is Executive Director of Humanity+, formerly the World Transhumanist Association, and is one of the co-authors of the 1998 Transhumanist Declaration.

Speaking toExpress.co.ukshe said: We certainly do need to upgrade our biology and Ive been speaking about this for 30-something years.

The fact that our biology is vulnerable. We exist on a daily basis with an incredible vulnerable vehicle, our bodies, that anything could go wrong at any time.

As far as genetic engineering goes weve seen great work done with certain diseases like Tay-Sachs and sickle-cell anemia, certain cancers, certain diseases that handicap us.

Other gene therapies are in the works and there still needs to be far more work in this area and I think most of us will be undergoing gene therapy as soon as it comes online as needed.

Say 50 years from now I think well be looking at alternative bodies and we can see that really growing in the field of prosthetics.

Transhumanists think human lifespans can be radically extended, with many believing ageing can be reversed and death from disease abolished.

Ms Vita-More argued future humans will look to backup the content of their brains as an insurance policy against death or injury.

She asserted: It is essential our memories be stored some place.

Currently our memories are stored in our brain but thats vulnerable. We have hackers all the time in our brains and those are called viruses and disease.

Disease is constantly hacking our neurons so in order to protect that we need to have copies of it, we need to back it up and you see certain industry leaders like Google looking at how to back up the brain.

I see uploading as a necessary technology for not only backing up the brain but as a means for us to go into different environments.

Were currently in this physical/material world, this biosphere, there are other worlds yet to be explored just as were looking at space exploration.

READ MORE:Oxford academic claims future humans could live for thousands of years

Another area is virtual reality, augmented reality, all these other systems even in games to go into games and participate as yourself taking on an avatar or maybe something else.

Asked about those who might object, on religious or moral grounds, to radical life extension Ms Vita-More expressed confidence their arguments would be overcome.

She commented: I think its largely religious but I think it is also innate.

I think the narrative is engrained in culturalization, it seems to be endemic across cultures.

Given that plus the largest percentage of people on our planet are religious that puts a damper on it too. However it doesnt prevent it.

It could be interesting if we see religious doctrines changing a little bit to include life extension and changing as weve seen with divorce.

If you believe an afterlife it doesnt have to happen at exactly a certain time. Maybe instead of 90 as a lifespan maybe 300 if you want to go that route.

So well see a realisation that religions have to keep up with the state of society and their members within that.

Ms Vita-More is also an advisor to the Singularity University and co-editor and contributing author to The Transhumanist Reader: Classical and Contemporary Essays on the Science, Technology, and Philosophy of the Human Future.

Asked what most excites her about the future she replied: I would like to totally reengineer my body, its not available yet but Id like to have a whole new body thats smoothly integrated not only with narrow artificial intelligence (AI) but with artificial general intelligence and Id like to have a metabrain where Id have AI working with me like a best friend or cohort.

Go here to see the original:
Humans will be able to replace their bodies within 50 years claims transhumanist writer - Express.co.uk

Global Cryonics Technology Market Projected to Reach USD XX.XX billion by 2025- Praxair, Cellulis, Cryologics, Cryotherm, KrioRus, VWR, etc. – News…

The study on Global Cryonics Technology Market , offers deep insights about the Cryonics Technology market covering all the crucial aspects of the market. Moreover, the report provides historical information with future forecast over the forecast period. Some of the important aspects analyzed in the report includes market share, production, key regions, revenue rate as well as key players. This Cryonics Technology report also provides the readers with detailed figures at which the Cryonics Technology market was valued in the historical year and its expected growth in upcoming years. Besides, analysis also forecasts the CAGR at which the Cryonics Technology is expected to mount and major factors driving markets growth. This Cryonics Technology market was accounted for USD xxx million in the historical year and is estimated to reach at USD xxx million by the end of the year 2025..

This study covers following key players:PraxairCellulisCryologicsCryothermKrioRusVWRThermo Fisher ScientificCustom Biogenic SystemsOregon CryonicsAlcor Life Extension FoundationOsiris CryonicsSigma-AldrichSouthern Cryonics

Request a sample of this report @ https://www.orbismarketreports.com/sample-request/82181?utm_source=Pooja

To analyze the global Cryonics Technology market the analysis methods used are SWOT analysis and PESTEL analysis. To identify what makes the business stand out and to take the chance to gain advantage from these findings, SWOT analysis is used by marketers. Whereas PESTEL analysis is the study concerning Economic, Technological, legal political, social, environmental matters. For the analysis of market on the terms of research strategies, these techniques are helpful.It consists of the detailed study of current market trends along with the past statistics. The past years are considered as reference to get the predicted data for the forecasted period. Various important factors such as market trends, revenue growth patterns market shares and demand and supply are included in almost all the market research report for every industry. It is very important for the vendors to provide customers with new and improved product/ services in order to gain their loyalty. The up-to-date, complete product knowledge, end users, industry growth will drive the profitability and revenue. Cryonics Technology report studies the current state of the market to analyze the future opportunities and risks.

Access Complete Report @ https://www.orbismarketreports.com/global-cryonics-technology-market-growth-analysis-by-trends-and-forecast-2019-2025?utm_source=Pooja

Market segment by Type, the product can be split into Slow freezingVitrificationUltra-rapid

Market segment by Application, split into Animal husbandryFishery scienceMedical sciencePreservation of microbiology cultureConserving plant biodiversity

For the study of the Cryonics Technology market it is very important the past statistics. The report uses past data in the prediction of future data. The keyword market has its impact all over the globe. On global level Cryonics Technology industry is segmented on the basis of product type, applications, and regions. It also focusses on market dynamics, Cryonics Technology growth drivers, developing market segments and the market growth curve is offered based on past, present and future market data. The industry plans, news, and policies are presented at a global and regional level.

Some Major TOC Points:1 Report Overview2 Global Growth Trends3 Market Share by Key Players4 Breakdown Data by Type and ApplicationContinued

For Enquiry before buying report @ https://www.orbismarketreports.com/enquiry-before-buying/82181?utm_source=Pooja

About Us : With unfailing market gauging skills, has been excelling in curating tailored business intelligence data across industry verticals. Constantly thriving to expand our skill development, our strength lies in dedicated intellectuals with dynamic problem solving intent, ever willing to mold boundaries to scale heights in market interpretation.

Contact Us : Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

Continued here:
Global Cryonics Technology Market Projected to Reach USD XX.XX billion by 2025- Praxair, Cellulis, Cryologics, Cryotherm, KrioRus, VWR, etc. - News...

COVID-19 Impact on Withania Somnifera Extract Market Development, Future, Importance and Forecast Report 2020 to 2025: Life Extension, Taos Herb…

Chicago, United States: The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the globalWithania Somnifera Extract Market. It includes Porters Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Withania Somnifera Extract Market. We have provided deep analysis of the vendor landscape to give you a complete picture of current and future competitive scenarios of the global Withania Somnifera Extract market. Our analysts use the latest primary and secondary research techniques and tools to prepare comprehensive and accurate market research reports.

Top Key players cited in the report: Life Extension, Taos Herb Company, General Nutrition Centers, Jarrow Formulas, Huge Mountain, Organic India, The Vitamin Shoppe, NOW Foods, Solgar, Piping Rock, Swanson

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart)

Each segment of the global Withania Somnifera Extract market is extensively evaluated in the research study. The segmental analysis offered in the report pinpoints key opportunities available in the global Withania Somnifera Extract market through leading segments. The regional study of the global Withania Somnifera Extract market included in the report helps readers to gain a sound understanding of the development of different geographical markets in recent years and also going forth. We have provided a detailed study on the critical dynamics of the global Withania Somnifera Extract market, which include the market influence and market effect factors, drivers, challenges, restraints, trends, and prospects. The research study also includes other types of analysis such as qualitative and quantitative.

Global Withania Somnifera Extract Market: Competitive Rivalry

The chapter on company profiles studies the various companies operating in the global Withania Somnifera Extract market. It evaluates the financial outlooks of these companies, their research and development statuses, and their expansion strategies for the coming years. Analysts have also provided a detailed list of the strategic initiatives taken by the Withania Somnifera Extract market participants in the past few years to remain ahead of the competition.

Global Withania Somnifera Extract Market: Regional Segments

The chapter on regional segmentation details the regional aspects of the global Withania Somnifera Extract market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and the anticipates its influence on the global Withania Somnifera Extract market.

The Middle East and Africa(GCC Countries and Egypt)North America(the United States, Mexico, and Canada)South America(Brazil etc.)Europe(Turkey, Germany, Russia UK, Italy, France, etc.)Asia-Pacific(Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Request For Customization @https://www.reporthive.com/request_customization/2311790

Report Highlights

Comprehensive pricing analysis on the basis of product, application, and regional segments

The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Withania Somnifera Extract market

Deep insights about regulatory and investment scenarios of the global Withania Somnifera Extract market

Analysis of market effect factors and their impact on the forecast and outlook of the global Withania Somnifera Extract market

A roadmap of growth opportunities available in the global Withania Somnifera Extract market with the identification of key factors

The exhaustive analysis of various trends of the global Withania Somnifera Extract market to help identify market developments

Table of Contents

Report Overview:It includes six chapters, viz. research scope, major manufacturers covered, market segments by type, Withania Somnifera Extract market segments by application, study objectives, and years considered.

Global Growth Trends:There are three chapters included in this section, i.e. industry trends, the growth rate of key producers, and production analysis.

Withania Somnifera Extract Market Share by Manufacturer:Here, production, revenue, and price analysis by the manufacturer are included along with other chapters such as expansion plans and merger and acquisition, products offered by key manufacturers, and areas served and headquarters distribution.

Market Size by Type:It includes analysis of price, production value market share, and production market share by type.

Market Size by Application:This section includes Withania Somnifera Extract market consumption analysis by application.

Profiles of Manufacturers:Here, leading players of the global Withania Somnifera Extract market are studied based on sales area, key products, gross margin, revenue, price, and production.

Withania Somnifera Extract Market Value Chain and Sales Channel Analysis:It includes customer, distributor, Withania Somnifera Extract market value chain, and sales channel analysis.

Market Forecast Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

Get Sample Copy of this report:https://www.reporthive.com/request_sample/2311790

About Us:Report Hive Research delivers strategic market research reports, statistical survey, and Industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of United States Business Leaders, Government Organizations, SMEs, Individual and Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio and application analysis etc.

Visit link:
COVID-19 Impact on Withania Somnifera Extract Market Development, Future, Importance and Forecast Report 2020 to 2025: Life Extension, Taos Herb...

How a pandemic and production war thrashed one of N.L.’s 4 producing oil fields – CBC.ca

Instead of producing oil offshore Newfoundland, the Terra Nova FPSO may soon become a longer-term fixture in Conception Bay, or dockside at a port like Bay Bulls.

That's not a good scenario for Newfoundland and Labrador's oil industry, the hundreds of workers linked to the aging oil production vessel, or a provincial treasury that can ill afford to lose the couple-hundred-million in oil royalties that typically flow from the Terra Nova each year.

The Terra Nova oil field was the second of four in the offshore to begin production, with first-oil from the Terra Nova FPSOreported in January 2002.

Since then, Suncor Energy and its partners have pumped more than 420 million barrels of oil from the field, nearly twice as much as the White Rose field, though well short of the more than 1.1 billion barrels at Hibernia.

Terra Nova averaged nearly 30,000 barrels of production each day in 2018 and 2019.

The oil companies long ago recovered their initial investment in the project, and as a result, oil royalties from the Terra Nova are the most lucrative for the province on a per capita basis.

But the vessel is near the end of its life, and it has been anything but smooth sailing for the past six months.

Now a deluge of ill winds have combined to cripple the operation, and derail a costly plan to overhaul the vessel to add adecade to its life and produce up to 80 million more barrels of oil.

There's a very real possibility that, once it leaves this summer, the Terra Nova FPSO might not return to the Grand Banks for up to two years. That's left workers on edge, with their futures very much in limbo.

So how did we get here?

The Terra Nova is showing its age. That's one factor. A global pandemic has also dealt a devastating blow to the world oil industry, with nearly every form of transportation practically seized up. And a production war between Saudi Arabia and Russia earlier this year drove stockpiles to the brim.

Newfoundland and Labrador is not exempt from these world events despite the coveted light, sweet crude that is produced in our offshore and the industry is now in crisis mode.

The challenges for the Terra Nova began in December, when theboard that regulates the offshore industry ordered a stop to production because of a safety deficiency related to fire suppression. Further inspections found more problems.

Suncor and the Canada-Newfoundland and Labrador Offshore Petroleum Boardhave been in talks for months, trying to reach an agreement that would allow the vessel to resume production.

Those talks recently broke down, with the partners unwilling to invest the estimated $150 million to $200 million required to get approval to operate from the board, according to sources.

And a six-month, $600-million plan to sail the Terra Nova to a dockyard in Spain last month for life-extension overhaul is in limbo because of the COVID-19 pandemic.

It's work that cannot be done in this province or Canada, for that matter sayinsiders, and missing the window of opportunity in Spain is a setback.

"We do not have an approved alternative for the asset life extension project," confirmed Suncor in a statement Friday.

What's more, the vessel's all-important certificate of fitness expires next summer, and certifying authorities likeLloyd's Register North Americawill demand a major refit before the Terra Nova resumes production.

So while plenty is still unknown, this is certain: the Terra Nova will soon be disconnected from its subsea production systemsand will sail into an uncertain future.

That's a blow for the province, on many levels.

According to a benefits report released by Suncor for the fourth quarter of 2019, atotal of 853 people were working with the Terra Nova project at the end of last year, and more than 90 per cent of them were residents of Newfoundland and Labrador.

What will become of those workers?

"Our people are very important to us.When a final decision is made on the path forward, we will work to understand the staffing requirements to support the plan and keep our team informed as decisions are made," Suncor stated in an email Friday.

The removal of the Terra Nova will also be felt by the supply and service sector,from helicopter and supply ship services to catering and personal protective equipment sales.

For the fourth quarter of 2019, there were more than 1,500 purchase orders related to the project, valued at $24 million. Nearly $16 million of those purchases were made from companies with locations in Newfoundland and Labrador.

It's little wonder the N.L. oil and gas industries association and its 600 members arein panic mode. Many of Noia's members have slashed jobs, and some have closed up shop, according to CEO Charlene Johnson.

But the union says it will continue to press for a solution, including a quicker return to production.

"We're trying to get this reversed. There is still some fight left in us yet," said Dave Mercer, president of Unifor Local 2121, which represents 400 workers involved with the Terra Nova.

Read more from CBC Newfoundland and Labrador

Original post:
How a pandemic and production war thrashed one of N.L.'s 4 producing oil fields - CBC.ca

The indoor farm revolution – Mashable SE Asia

NOTE FOR 2020 READERS: This is the eleventh in a series of open letters to the next century, now just 80 years away. The series asks: What will the world look like at the other end of our kids' lives?

Dear 22nd Century,

For all the pain, grief and economic hardship the 2020 coronavirus pandemic has sown, a handful of green shoots seem to have taken root in its blighted soil.

Green being the operative word, because many of these developments could be a net positive for the planet. In lockdown, many of us are seeing what our cities look like without smog. Office workers are experiencing office life without the office; just last week, Twitter announced that most of its employees could work from home forever, while much of Manhattan is reportedly freaking out about what could happen to commercial real estate. Thousands of companies just discovered they can still function, and maybe even function better, when they dont chain employees to desks or force them to make a soul-crushing, carbon-spewing commute 10 times a week.

And what do more people do when theyre spending more time at home? Well, if youre like my wife, you start literally planting green shoots. Our house is filling up with them as I write this: lettuce, chard, tomatoes, basil, strawberries, to name the first five shoots poking out of dozens of mason jars now taking up residence on every windowsill. Shes hardly alone; garden centers and seed delivery services are reporting as much as 10 times more sales since the pandemic began. Even the mighty Wal-Mart has sold out of seeds. Ifviral Facebook postsand Instagram hashtags are any guide, pandemic hipsters have moved on from once-fashionable sourdough starters to growing fresh fruit and veg.

Another one of our cyclical back to the land movements seems to be underway, just like during the 1960s and the Great Depression before that. Only this time, we dont need land. We dont need soil. We dont need pesticide of any kind. We dont even need natural light. Thanks to giant leaps forward in the science of hydroponics and LED lighting, even people in windowless, gardenless apartments can participate in the revolution. With a number of high-tech consumer products on the way, the process can be automated for those of us without green thumbs.

In previous letters Ive discussed the inevitable rise of alternative meat, a process that has been acceleratedby the pandemic. I talked about the smaller, more nutritious plant-based meals we're going to need for life extension; I assumed such meals would be delivered by drone. But now I see a future with no food deserts, in which every home is filled with rotating space-station-like hydroponics run by artificial intelligence a cornucopia of push-button farming providing the side salad to your plant-based meat.

Even if you dont grow your own, robot-run vertical farms and community agrihoods, now springing up everywhere, will make amazing-tasting produce abundant and cheap. The locavores of our era like to boast about their 100-mile diet. Yours will look more like a 100-yard diet.

Its worth remembering that it wasnt supposed to be this way. The 2020s, in fact, is when we were slated for starvation, food riots, and big business quietly processing our corpses into food.

Thats the plot of the 1973 movie Soylent Green, set in the year 2022. Fruit and veg have all but vanished. In one scene, Charlton Heston's detective hero smuggles home a single tomato and a wilted stick of celery, enough to reduce his roommate Sol (Edward G. Robinson) to tears. On the other end of the future, in a lighter but equally depressing vein, the 2006 comedy Idiocracy showed the Americans of 2500 running out of crops because they couldnt figure out that water, not "Brawndo" (a spoof on colorful sports drinks), is what plants crave.

But these dismal future visions are receding thanks to the science of hydroponics which dates back to the 19th century, no matter its present-day association with growing marijuana. By the 1930s, wed figured out that what plants crave is surprisingly minimal: nitrogen, a handful of minerals, something to anchor the roots like rock wool or coconut husks, and H2O. Early hydroponic farms helped feed U.S. soldiers as they hopped through the Pacific during World War II.

Minimalist methods multiplied, and are still multiplying. Were tweaking the spectrum of LED lights for maximum growth, and figuring out ways to use progressively less water and nutrients. My wifes mason jar seedlings use something called the Kratky method, where you don't even need to change the water. It turns out this method wasinvented by a Hawaiian scientist as recently as 2009. And its the closest science has yet given us to a free lunch.

Im nowhere near as excited by hydroponics as my wife is. But during our quarantine time, even my head has been turned by the Rotofarm, which Ive come to think of as the iPhone of gardening. Its a beautiful device inspired by NASA research on growing plants in space. It uses anti-gravity literally, when the wheel rotates around its LED light source and the plants are hanging upside down to grow plants faster. A magnetic cover reduces the glare and increases the internal humidity. You manage it via an app.

Humankinds oldest technology turns out to be the most efficient use of space for growing plants; even in this 15-inch-wide wheel, you can really pack them in. At the bottom of the wheel, plants dip their roots into the water and nutrient tanks. An owners only job is to refill the tanks every week or so, and to snip off their dinner with scissors a few weeks after germination. Some leafy greens, like my favorite salad base arugula, can be regrown without replanting.

Still, to be fully self-sufficient, a future apartment is going to need to have multiple Rotofarm-style devices on the go at once but theyre designed to live anywhere you can plug in, on coffee tables, on desks, on walls, as eye-catching as artwork.

The main problem with the Rotofarm: It isnt actually on sale yet. It feels like weve done everything in reverse, Rotofarm creator Toby Farmer said when I reached him via video chat from his home in Melbourne. Weve got the patents, weve got the design awards, weve got the customers. Now we need to finish the prototypes. (One key tweak: reducing Rotofarms energy requirements, which as it stands could double many users household electricity bills.)

Still, orders have come from as far afield as Japan and the Netherlands, from retailers and regular users alike. Farmers biggest regret: When Ron Howards production company called, hoping to use eight Rotofarms in an upcoming Nickelodeon show set in space, Farmer didnt have enough to spare.

Rotofarm has been in the works for a few years, but acrowdfunded Indiegogocampaign that closed last month exceeded its $15,000 goal by a third of a million dollars. Farmer, despite his name, had no experience in this area; just 23 years old, he had been a web designer since the age of 12. But hes scaling up fast, hiring teams in LA and Singapore, soaking up their knowledge (he was keen to assure me hed hired a lot of 40-somethings for this very reason).

After a projected 2021 release date, Rotofarms business model involves making money on proprietary seed pods though Farmer admits that theres a DIY aspect where customers can make their own. His hope is that official Rotofarm pods will be competitive because theyll have fewer germination failures, but he'd rather see a world where more people own the device itself. In that spirit, hes making it modular the LED light bar can be upgraded separately, for example, rather than making customers buy a whole new device. (As for cost, Farmer says he can't comment yet though Indiegogo backers were able to secure one for $900 a pop.)

Might the Rotofarm fail? Of course, just like any other crowdfunded project. Much depends on its price point, as yet unannounced. But its far from the only next-level, set-it-and-forget-it hydroponic station taking aim at your kitchen. Theres a Canadian Kickstarter called OGarden that also grows food on a wheel, albeit a much larger wheel. The OGarden was funded in its first six minutes online and is set to cost around $1,000 per unit. Theres Farmshelf, a $4,900 pre-order hydroponic device that looks like a see-through refrigerator, backed by celebrity chef Jose Andres. Users will pay a $35 monthly subscription to get all the seeds they need.

One of these models is the future; maybe all of them are. Right now, these are high-end devices aimed at early adopters (and restaurants, which get a lot of benefit out of showing off how fresh their produce is as customers walk in). But with scale, with time, and with the growing desire for grow-your-own food that Rotofarm and its brethren have revealed, they will get cheaper and more widespread.

After all, the first Motorola cellphone, in 1983, cost $4,000. It looked like a brick and had 30 minutes of talk time. Now sleek, supercomputer-driven smartphones are accessible to pretty much everyone. The same process will happen in home hydroponics.

Give it 80 years, and I can see apartments with built in hydroponic farms provided as a standard utility, much as a fridge is seen as a standard feature today. As more humans move to urban environments two out of every three people will be in cities by 2050, according to the latest UN estimate the need for such devices will only grow.

We strongly believe the future of gardening is indoor gardening and more individual gardens, OGarden CEO Pierre Nibart told us last year. Stopping mass agriculture and starting to produce their own little stuff at home. He said this while demonstrating his family's daily OGarden routine: His kids harvest most of what they need for dinner from the spinning wheel.

Mass agriculture hasnt exactly covered itself in glory where produce is concerned. And in the post-coronavirus age, we are surely going to become less tolerant of the disease its intensive farming methods have caused.

Food poisoning caused by romaine lettuce, which makes up a quarter of all leafy greens sold in the U.S., has become depressingly familiar. The 2018 E coli outbreak was the worst it sickened 240 people in 37 states, hospitalized almost half of them, and killed five. But the CDC has logged 46 E coli outbreaks since 2006, and says that every reported case of infection is likely matched by 26 unreported ones. And theyre only just starting to figure out the most likely cause: groundwater contaminated by nearby cattle manure. There could also be infection from passing birds, another major vector of bacteria.

Never mind the wet markets of Wuhan that likely caused the coronavirus pandemic. Were already sickening ourselves on the regular with a problem that is baked directly into our food system and its affecting vegans as much as meat eaters.

I have no doubt youll look at our barbaric farming methods and shake your heads. Why did they use so much water? Why did they transport produce an average of 1,500 miles? Why did they grow it outdoors, where its vulnerable to pests, and then use pesticides that had to be washed off? Why did they think triple washing did anything to remove bacteria (it doesnt)? Why did they bother using soil, for goodness sake? Didnt they know what plants crave?

The force of legacy agriculture is strong, but an increasing number of companies are figuring out a better way: the vertical farm, so named because they can stack hydroponic produce in shelves or towers. As I write this, there are more than 20 vertical farm operations being constructed and tested around the country. They use around 90 percent less water than regular soil farms, can grow roughly 10 times more food per acre than regular soil farms, and using precision software they can harvest their produce 30 percent faster than regular soil farms.

Sure, theyre spending more on electricity, but theyre also spending nothing on pesticide. The economics seem irresistible.

Last year, less than 20 miles from where I write this, in highly urbanized South San Francisco, a company called Plenty unveiled its flagship operation, a vast vertical farm named Tigris. Its sheer scale invites the correct usage of Californias favorite word, awesome. Tigris can grow a million plants at once, harvesting 200 of them every minute. With $226 million in funding, Plenty says it has already farmed 700 varieties of produce. Right now, the cost to consumers is comparable to non-hydroponic products (I can get their baby arugula at my nearest Safeway for a dollar an ounce); in the long run, it should be cheaper.

And they are far from the only success story. A Chinese startup, Alesca Life, is turning disused parking lots into vertical farms as well as selling plug-and-play shipping container farms. Back in Silicon Valley, a company called Iron Ox is developing robot arms for indoor farmwork. The future looks green, and bountiful, and mostly automated (which is yet another reason youre going to need Universal Basic Income).

Which is not to say that outdoor agriculture is going away completely; its just going to shrink to the size of a community garden. Thats the basis of new urban developments called agrihoods, or multihome communities centered around a professionally managed farm; a just-published book called Welcome to the Agrihoodrepresents their first directory.

Rooftop organic farms, urban allotments: These are places where city dwellers can connect to the land and feel the satisfaction of nurturing their seeds from scratch. Soil may not be necessary to feed us, but sometimes its good to feel the dirt in your fingers. Similarly, farmer's markets are unlikely to go away. In a world where grocery stores are increasingly becoming delivery centers for services like Instacart, there will still be value in meeting and buying direct from the growers of high-end produce.

With big agribusiness heading indoors, with our apartments growing much of what we need and vertical farms providing backup in every city, well also be able to let most of our present-day farmland go fallow. That in itself should take care of a chunk of climate change, considering the amount of carbon-soaking vegetation that springs up on fallow land. Lab-grown and plant-made meat will remove the need for those disease-ridden feedlots. Aquaponics, another discipline where the science is expanding by leaps and bounds, may even let us grow our own fish for food, reducing the strain on our overfished oceans.

No doubt it wont be all smooth sailing. No doubt we, as humans, will stumble upon fresh ways to mess up the planet and make life worse. But from where Im sitting, surrounded by soilless germinating jars, the future looks very green and nutritious indeed.

Yours in leafy goodness,

2020

View original post here:
The indoor farm revolution - Mashable SE Asia

Dual-Ovenable Trays & Containers Market Increasing Demand with Key Players COVID-19 Impact Analysis – Cole of Duty

A dual-Ovenable tray is useful for the purpose of supporting a food product. The tray comprises of a sheet having first & second layers comprising one or more polyamides. The first layer of the sheet forms tray inside surface. Where the first layer has got a melting point, the second layer has the melting point of at max about 210 C. & at least 20 C. greater than melting point of the first layer. Where the first layer has a glass transition temperature of less than about 120 C. measured at a 50% relative humidity, the second layer has a melting point of at least about 210 C.

Request For Report Sample:https://www.trendsmarketresearch.com/report/sample/3025

Most plastics deform at the high temperatures but the dual ovenable trays and containers can resist when the heat applications are very high and are bakeable in any conventional or microwave oven without getting melted or without de-forming. They keep the oven clean & preserve the food contained within it. Material used for the dual ovenable trays and containers provides outstanding shelf life extension & appearance appeal.

In terms of material type, thedual-ovenable trays & containers marketis bifurcated into paperboard, C-PET, A-PET, PP, PE, and others. The C-PET segment is estimated to dominate the market throughout forecast period having an estimated market share of around 88.7% in 2018. The PP segment is estimated to register the CAGR of around 3.3% during forecast period. Paperboard segment is estimated to create an incremental dollar opportunity of US$ 29 Mn during forecast period. Based on material, the CPET segment accounted for the considerable market share during forecast period.

CPET is the most adaptable option for the ready meals attributed to easily seal & most affordable. CPET trays withstand temperatures ranging from -40 to +220 C. In terms of geography, North America is expected to have largest market share during forecast period in the region due to increase in the consumption of ready-to-eat meals. Elisabeth Skoda explores recent innovations in the area of ovenable and microwavable packaging.

Terinex has introduced the new Q-Tex film, a heat sealable PET mono layer HD printed food grade ovenable film, which is suitable for freezer, microwave and oven usage. The Q-Tex film has one layer instead of the two found in laminate alternatives, therefore offering material reduction and easier recyclability.

Some of the key players profiled in this market include Bemis Company, Inc., Sealed Air Corporation, Dupont Teijin Films, Genpak, LLC, Evergreen Packaging, Inc., Sonoco Products Company, Oliver Packaging & Equipment Co., MCP Performance Plastic Ltd, CiMa-Pak Corporation, PinnPACK Packaging LLC, PAC Food Pty Ltd., Sanplast Ltd, Pactiv LLC, Plastic Package, Inc.

More Info of Impact Covid19 @ https://www.trendsmarketresearch.com/report/dual-ovenable-trays-and-containers-market

See the rest here:
Dual-Ovenable Trays & Containers Market Increasing Demand with Key Players COVID-19 Impact Analysis - Cole of Duty

The Navy’s Next Jet Trainer Won’t Be Able To Land Or Take Off From An Aircraft Carrier – The Drive

It's not clear from the contracting notice if the land-based design would actually be the only replacement for the T-45, as NAVAIR itself has made clear that it will only be able to meet "certain requirements" for the UJTS program. The War Zone has already reached out for additional information and clarification.

It's certainly true that the T-45s, of which the Navy and the Marine Corps have around 194 in service in total, the oldest of which are now more than three decades old, are increasingly in need of a replacement. The Navy had originally planned to phase them all out in 2018, but, five years before, made to decision to instead extend their service life through 2042. The Goshawks fleet's readiness rates have slipped in recent years, raising concerns about the service's ability to train an adequate number of pilots each year. In 2019, the Government Accountability Office also warned about potential shortfalls in available aircraft as jets went through the planned Service Life Extension Program.

The T-45 fleet also suffered a worrying and deadly spate of hypoxia incidents between 2016 and 2017. Various fixes to the aircraft themselves, as well as the Navy's operating procedures, have reduced the number of subsequent physiological events in the past three years, but identifying the underlying root causes has proven difficult.

Buying an existing land-based design made to Navy specifications, but without having to modify it to withstand the stresses of catapult launches and arrested landings, could offer a low-cost, low-risk path for the Navy to acquire new jet trainers. One obvious option would be to acquire a version of the U.S. Air Force's new T-7A Red Hawk, the production of which started in January. The War Zone has already detailed the many possible future roles for the T-7A, or derivatives thereof, in the past.

There are also a number of other proven and in-production land-based jet trainer designs available, including the losing entrants for the Air Force's T-X competition, which the T-7A won. The Air Force itself recently exploring buying a small number of South Korean-made KAI T-50 Golden Eagles to support its own transformational fighter jet pilot training plans. That service canceled its proposed sole-source purchase of the T-50s in March and now says it will hold an open competition.

At the same time, whatever cost-savings the Navy might find by pursuing this course of action might be offset, at least in part, by changes that would then be necessary to its fighter pilot training pipeline. Those aviators will still need to conduct carrier qualifications and will need suitable aircraft in which to perform them. Even simply using existing F/A-18E/F Super Hornets to meet these requirements would increase the number of flight hours those jets have to dedicate to training missions, potentially pulling them away from other activities. These full-up fighters are also costly to operate.

It is worth noting that the Navy is making substantial investments in developing and fielding various technologies to help automate carrier landings. It is possible that this could eventually reduce the amount of required carrier qualification training the service feels is required, but it wouldn't eliminate it entirely. At the same time, carrier qualifications have been getting steadily pushed farther and farther down the pipeline.

The Navy has already done something broadly similar with regards to its C-2 Greyhound andE-2 Hawkeye aircraft. Prospective pilots destined to fly those aircraft conduct much of their training in the T-44, a variant of the Beechcraft King Air, which is also not carrier-capable. It's not clear how that training pipeline may also now change as the C-2s get replaced by the CMV-22B Osprey tilt-rotor. Still, as long as manned fighter jets operate from its carriers, there will be a need to have those pilots practice the uniquely complicated process of landing on, as well as taking off from, those flattops.

Regardless, the Navy's plans to buy non-carrier-capable jet trainers to replace its T-45s, even in part, points to major changes coming in how the service prepares prospective fighter pilots for the challenges involved in joining its carrier air wings.

Contact the author: joe@thedrive.com

Read more:
The Navy's Next Jet Trainer Won't Be Able To Land Or Take Off From An Aircraft Carrier - The Drive

How COVID-19 might affect US nuclear weapons and planning – Brookings Institution

The Department of Defense has begun to ratchet up spending to recapitalize the U.S. strategic nuclear triad and its supporting infrastructure, as several programs move from research and development into the procurement phase. The projected Pentagon expenditures are at least $167 billion from 2021-2025. This amount does not include the large nuclear warhead sustainment and modernization costs funded by the Department of Energy, projected to cost $81 billion over the next five years.

Nuclear forces require modernization, but that will entail opportunity costs.In a budget environment that offers little prospect of greater defense spending, especially in the COVID19 era, more money for nuclear forces will mean less funding for conventional capabilities.

That has potentially negative consequences for the security of the United States and its allies. While nuclear forces provide day-to-day deterrence, the Pentagon leadership spends most of its time thinking about how to employ conventional forces to manage security challenges around the world. The renewed focus on great power competition further elevates the importance of conventional forces. It is important to get the balance between nuclear and conventional forces right, particularly as the most likely path to use of nuclear arms would be an escalation of a conventional conflict. Having robust conventional forces to prevail in or deter a conventional conflict in the first place could avert a nuclear crisis or worse.

For the foreseeable future, the United States will continue to rely on nuclear deterrence for its security and that of its allies (whether we should be comfortable with that prospect is another question).Many U.S. nuclear weapons systems are aging, and replacing them will cost money, lots of money.The Pentagons five-year plan for its nuclear weapons programs proposes $29 billion in fiscal year 2021, rising to $38 billion in fiscal year 2025, as programs move from research and development to procurement.The plan envisages a total of $167 billion over five years.And that total may be understated; weapons costs increase not just as they move to the procurement phase, but as cost overruns and other issues drive the costs up compared to earlier projections.

The Pentagon knew that the procurement bow wave of nuclear weapons spending would hit in the 2020s and that funding it would pose a challenge.In October 2015, the principal deputy undersecretary of defense said Were looking at that big bow wave and wondering how the heck were going to pay for it and probably thanking our stars that we wont be here to have to answer the question.

The Pentagons funding request for fiscal year 2021 includes $4.4 billion for the new Columbia-class ballistic missile submarine that will replace Ohio-class submarines, which will begin to be retired at the end of the decade; $1.2 billion for the life extension program for the Trident II submarine-launched ballistic missile (SLBM); $1.5 billion for the Ground Based Strategic Deterrent, an intercontinental ballistic missile (ICBM) to replace the Minuteman III ICBM; $2.8 billion for the B-21 stealth bomber that will replace the B-1 and B-2 bombers; $500 million for the Long-Range Standoff Missile that will arm B-52 and B-21 bombers; and $7 billion for nuclear command, control and communications systems.

The Pentagon funds primarily go to delivery and command and control systems for nuclear weapons.The National Nuclear Security Administration at the Department of Energy bears the costs of the warheads themselves. It seeks $15.6 billion for five nuclear warhead life-extension and other infrastructure programs in fiscal year 2021, the first year of a five-year plan totaling $81 billion.The fiscal year 2021 request is nearly $3 billion more than the agency had earlier planned to ask, which suggests these programs are encountering significant cost growth.

Some look at these figures and the overall defense budget (the Pentagon wants a total of $740 billion for fiscal year 2021) and calculate that the cost of building and operating U.S. nuclear forces will amount to only 6-7 percent of the defense budget.That may be true, but how relevant is that figure?

By one estimate, the cost of building and operating the F-35 fighter program for the U.S. Air Force, U.S. Navy and U.S. Marines over the programs lifetime will be $1 trillion.Amortized over 50 years, that amounts to $20 billion per year or only 2.7 percent of the Defense Departments fiscal year 2021 budget request.The problem is that these percentages and lots of other small percentages add up.When one includes all of the programs, plus personnel and readiness costs as well as everything else that the Pentagon wants, the percentages will total to more than 100 percent of the figure that Congress is prepared to appropriate for defense.

The defense budget is unlikely to grow.Opportunity costs represent the things the Pentagon has to give up or forgo in order to fund its nuclear weapons programs.The military services gave an indication of these costs with their unfunded priorities lists, which this year total $18 billion.These show what the services would like to buy if they had additional funds, and that includes a lot of conventional weapons.

The Air Force, for example, would like to procure an additional twelve F-35 fighters as well as fund advance procurement for an additional twelve F-35s in fiscal year 2022. It would also like to buy three more tanker aircraft than budgeted.

The Army is reorienting from counter-insurgency operations in places such as Afghanistan and Iraq to facing off against major peer competitors, that is, Russia and China.Its wish list includes more long-range precision fires (artillery and short-range surface-to-surface missiles), a new combat vehicle, helicopters and more air and missile defense systems.

The Navy would like to add five F-35s to its aircraft buy, but its bigger desire is more attack submarines and warships, given its target of building up to a fleet of 355 ships. The Navy termed a second Virginia-class attack submarine its top unfunded priority in fiscal year 2021.It has set a requirement for 66 attack submarines and currently has about 50.However, as older Los Angeles-class submarines retire, that number could fall to 42. Forgoing construction of a Virginia-class submarine does not help to close that gap.

Moreover, the total number of Navy ships, now 293, will decline in the near term, widening the gap to get to 355.The Navys five-year shipbuilding program cut five of twelve planned Arleigh Burke-class destroyers, and cost considerations have led the Navy to decide to retire ten older Burke-class destroyers rather than extend their service life for an additional ten years.This comes when China is rapidly expanding its navy, and Russian attack submarines are returning on a more regular cycle to the Atlantic Ocean.

The Navy has said that funding the first Columbia-class ballistic missile submarine forced a cut-back in the number of other ships in its fiscal 2021 shipbuilding request.The decision not to fund a second Virginia-class attack submarine appears to stem directly from the unexpected $3 billion plus-up in funding for the National Nuclear Security Administrations fiscal year 2021 programs.

These are the opportunity costs of more nuclear weapons:fewer dollars for aircraft, ships, attack submarines and ground combat equipment for conventional deterrence and defense.

The principal driving factor behind the size of U.S. nuclear forces comes from Russian nuclear forces and doctrine.Diverse and effective U.S. nuclear forces that can deter a Russian nuclear attack should suffice to deter a nuclear attack by any third country.In contrast to the Cold War, the U.S. military no longer seems to worry much about a bolt from the bluea sudden Soviet or Russian first strike involving a massive number of nuclear weapons designed to destroy the bulk of U.S. strategic forces before they could launch.That is because, under any conceivable scenario, sufficient U.S. strategic forcesprincipally on ballistic missile submarines at seawould survive to inflict a devastating retaliatory response.

The most likely scenario for nuclear use between the United States and Russia is a regional conflict fought at the conventional level in which one side begins to lose and decides to escalate by employing a small number of low-yield nuclear weapons, seeking to reverse battlefield losses and signal the strength of its resolve.Questions thus have arisen about whether Russia has an escalate-to-deescalate doctrine and whether the 2018 U.S. nuclear posture review lowers the threshold for use of nuclear weapons.

If the United States and its allies have sufficiently robust conventional forces, they can prevail in a regional conflict at the conventional level and push any decision about first use of nuclear weapons onto the other side (Russia, or perhaps China or North Korea depending on the scenario).The other side would have to weigh carefully the likelihood that its first use of nuclear weapons would trigger a nuclear response, opening the decidedly grim prospect of further nuclear escalation and of things spinning out of control.The other sides leader might calculate that he/she could control the escalation, but that gamble would come with no guarantee. It would appear a poor bet given the enormous consequences if things go wrong.Happily, the test has never been run.

This is why the opportunity costs of nuclear weapons programs matter. If those programs strip too much funding from conventional forces, they weaken the ability of the United States and its allies to prevail in a conventional conflictor to deter that conflict in the first placeand increase the possibility that the United States might have to employ nuclear weapons to avert defeat.

For the United States and NATO members, that could mean reemphasis on an aspect of NATOs Cold War defense policy. In the 1960s, 1970s and early 1980s, NATO allies faced Soviet and Warsaw Pact conventional forces that had large numerical advantages, and NATO leaders had doubts about their ability to defeat a Soviet/Warsaw Pact attack at the conventional level.NATO policy thus explicitly envisaged that, if direct defense with conventional means failed, the Alliance could deliberately escalate to nuclear weapons.That left many senior NATO political and military officials uneasy.Among other things, it raised uncomfortable questions about the willingness of an American president to risk Chicago for Bonn.

Russia found itself in a similar situation at the end of the 1990s.With a collapsing economy following the break-up of the Soviet Union, the Russian government had to cut defense spending dramatically.As its conventional capabilities atrophied, Moscow adopted a doctrine envisaging first use of nuclear weapons to compensate.(In the past fifteen years, as Russias defense spending has increased, a significant amount has gone to modernizing conventional forces.)

The United States and NATO still retain the option of first use of nuclear weapons.If the U.S. president and NATO leaders were to consider resorting to that option, they then would be the ones to have to consider the dicey bet that the other side would not respond with nuclear arms or that, if it did, nuclear escalation somehow could be controlled.

Assuring NATO allies that the United States was prepared to risk Chicago for Bonn consumed a huge amount of time and fair amount of resources during the Cold War.At one point, the U.S. military deployed more than 7000 nuclear weapons in Europe to back up that assurance.Had NATO had sufficiently strong conventional forces, the Alliance would have been able to push that risky decision regarding nuclear first use onto Moscowor even have been able to take comfort that the allies conventional power would suffice to deter a Soviet/Warsaw Pact attack.

In modernizing, maintaining and operating a safe, secure and effective nuclear deterrent, the United States should avoid underfunding conventional forces in ways that increase the prospect of conventional defeat and/or that might tempt an adversary to launch a conventional attack.If Washington gets the balance wildly out of sync, it increases the possibility that the president might face the decision of whether to use nuclear weapons firstknowing that first use would open a Pandoras box of incalculable and potentially catastrophic consequences.

This means that the Department of Defense and Congress should take a hard look at the balance.The Pentagon presumably has weighed the trade-offs, though it is not a unitary actor. Nuclear weapons are our top priority has been the view of the leadership.The trade-offs have been easier to manage in the past several years, when nuclear programs were in the research and development phase, and defense budgets in the first three years of the Trump administration grew.As nuclear programs move into the more expensive procurement phase and the fiscal year 2021 budget shows little increase, the challenge of getting the balance right between nuclear and conventional spending has become more acute.It is not apparent that the Pentagon has weighed the opportunity costs over the next ten-fifteen years under less optimistic budget scenarios.

As for Congress, which ultimately sets and approves the budget, no evidence suggests that the legislative branch has closely considered the nuclear vs. conventional trade-offs.

All that was before COVID19.The response to the virus and dealing with the economic disruption it has caused have generated a multi-trillion-dollar budget deficit in 2020 and likely will push up deficits in at least 2021.It would be wise now to consider the impact of COVID19.

Having added trillions of dollars to the federal deficit, and facing an array of pressing health and social needs, will Congress be prepared to continue to devote some 50 percent of discretionary funding to the Department of Defenses requirements?Quite possibly not.If defense budgets get cut, the Pentagon will face a choice: shift funds from nuclear to conventional force programs, or accept shrinkage of U.S. conventional force capabilities andas the United States did in the 1950s and early 1960srely on nuclear deterrence to address a broader range of contingencies. In the latter case, that would mean accepting, at least implicitly, a greater prospect that the president would have to face the question of first use of nuclear weapons, i.e., a conventional conflict in which the United States was losing.

This is not to suggest that the U.S. military should forgo the strategic triad.Trident II SLBMs onboard ballistic missile submarines at sea remain the most survivable leg of the strategic deterrent.The bomber/air-breathing leg offers flexibility and can carry out conventional missions.The ICBM leg provides a hedge against a breakthrough in anti-submarine warfare.Moreover, if in a crisis or a conventional conflict, the Russian military were to develop the capability to attack U.S. ballistic missile submarines at sea, the Kremlin leadership might well calculate that it could do so without risking a nuclear response.Attacking U.S. ICBMs, on the other hand, would necessitate pouring hundreds of nuclear warheads into the center of America.A Russian leader presumably would not be so foolish as to think there would be no nuclear retaliation.

While sustaining the ICBM leg, one can question whether maintaining 400 deployed ICBMs, as the current plan envisages, is necessary.Reducing that number for the Ground-Based Strategic Deterrent (GBSD) would achieve budget savings, albeit later in the production run. Another question is whether some way might be found to extend the service life of some portion of the current Minuteman III force that would allow delaying the GBSD program, which is projected to cost $100 billion, by ten-fifteen years and postponing those costsfreeing up funds in the near term for conventional force requirements.

Another issue concerns the Long-Range Standoff Missile (LRSO) and its cost, estimated at some $20 billion when including the nuclear warheads.The B-21 bomber will incorporate stealth and advanced electronic warfare capabilities allowing it to operate against and penetrate sophisticated air defenses.The LRSO, to be deployed beginning in 2030, is intended to replace older air-launched cruise missiles carried by the B-52 bomber and could later equip the B-21 if it loses its ability to penetrate.

An alternative plan would convert B-52s in 2030 to conventional-only missions and delay the LRSO to a future point if/when it appeared that the B-21s ability to penetrate could come into question.By 2030, the Air Force should have a significant number of B-21s (the B-21 is scheduled to make its first flight in 2021 and enter service in 2025).With at least 100 planned, the Air Force should have a sufficient number of B-21s for the 300 nuclear weapons it appears to maintain at airfields where nuclear-capable bombers are currently based.

These kinds of ideas would free up billions of dollars in the 2020s that could be reallocated to conventional weapons systems.Delaying the GBSD and LRSO and their associated warhead programs by just one year (fiscal year 2021) would make available some $3 billionenough money for a Virginia-class attack submarine. Delaying those programs for ten-fifteen years would make tens of billions of dollars available for the militarys conventional force needs.

All things being equal, it is smarter and more efficient to choose to make decisions to curtail or delay major programs rather than to continue them until the money runs out and forces program termination. As it examines the administrations proposed fiscal year 2021 defense budget, Congress should carefully consider the trade-offs and press the Pentagon to articulate how it weighed the trade-offs between nuclear and conventional forces. In the end, Congress should understand whether it is funding the force that is most likely to deter not just a nuclear attack, but to deter a conventional conflict that could entail the most likely path to nuclear war.

See original here:
How COVID-19 might affect US nuclear weapons and planning - Brookings Institution

Archives